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CHAPTER 1 INTRODUCTION 
The DNA in the nucleus of eukaryotic cells contains genes that determine 
development, health and response to environmental challenges.  Appropriate control of 
these genes is essential for each of these processes to proceed correctly.  For this 
reason, the study of gene regulation is one of the most active and important areas of 
genetics.  Gene regulation is usually studied in the context of local regulatory elements 
that control individual genes. However, eukaryotic genomes are organized into large 
domains of coordinated regulation.  For example, the imprinted loci of mammals are 
clusters of genes that display regulatory patterns determined by marks placed in the 
parental germ line (Reik and Walter, 2001).  Coordinated regulation of large domains is 
essential, and failure may lead to developmental abnormalities, genetic disorders, birth 
defects or cancer (Culbertson, 1999; Emilsson et al., 2008; Lamb et al., 2006). An 
extraordinary example of domain-wide regulation is modulation of sex chromosome 
expression, a process known as dosage compensation. In many heterogametic 
organisms, males have one X chromosome while females have two.  In flies and 
mammals the X chromosome is gene-rich, while the Y chromosome has few but very 
important genes.  Males are thus hemizygous for a large number of genes.  The 
maintenance of a similar X to autosome expression ratio in males and females is 
essential for viability.  Different strategies for accomplishing this have evolved 
independently.  In mammals, females inactivate one of their X chromosomes.  X 
inactivation is initiated and sustained by X-inactive specific transcript (XIST), a long non-
coding RNA (Lee, 2009). In C. elegans, gene expression from each of the two 
hermaphrodite X chromosomes is reduced by half (Meyer, 2000). In Drosophila 
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melanogaster, males double transcribe almost all X-linked genes.  Although these 
strategies appear dramatically different, they all are achieved by modification of 
chromatin on the affected chromosome  (Lucchesi and Kuroda, 2015).  Consequently, 
each system must be able to selectively identify a single chromosome.  How this is 
achieved is poorly understood. The subject of my dissertation is a study of DNA 
elements that contribute to this process in flies. 
Dosage compensation in D. melanogaster males 
In Drosophila melanogaster, dosage compensation involves the Male Specific 
Lethal (MSL) complex.  The MSL complex is recruited to the body of X-linked genes, 
where it modifies chromatin to increase transcription of the male X chromosome 
(Lucchesi and Kuroda, 2015). The MSL complex consists of one of two long non-coding 
RNA on the X transcripts (roX1 or roX2) and five proteins, MSL1, -2, and -3, Maleless 
(MLE), and Males Absent on the First (MOF) (Gelbart and Kuroda, 2009; Quinn et al., 
2014). Formation of the MSL complex is limited to males by the female-limited Sexlethal 
protein (Sxl) (Bashaw and Baker, 1997; Beckmann et al., 2005; Kelley et al., 1995).  Sxl 
blocks MSL2 translation (Gebauer et al., 1998).  MSL2 is the only male-limited protein in 
the MSL complex, and expression of MSL2 in the male zygote at 3 h after embryo 
laying (AEL) triggers formation of the intact MSL complex and X localization (Meller, 
2003). MSL1 provides a scaffold for the complex through interactions with MSL2, MOF 
and MSL3 (Morales et al., 2004; Scott et al., 2000). MOF is a histone acetyl transferase 
(Hilfiker et al., 1997).  The MSL complex acetylates histone 4 lysine 16, and this mark is 
associated with increased gene expression by enhanced transcriptional elongation 
(Larschan et al., 2011; Smith et al., 2000).  MSL2 has been shown to have 
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ubiquitinating activity, but the role of this in dosage compensation remains unclear (Wu 
et al., 2011).   
While elimination of any one of the MSL proteins is lethal to males, roX1 and 
roX2 appear fully redundant for compensation (Meller and Rattner, 2002).  Loss of both 
roX transcripts results in male lethality around the time of pupation.  In these males the 
MSL proteins are mislocalized to ectopic autosomal sites, and X-linked gene expression 
is reduced (Deng and Meller, 2006; Meller and Rattner, 2002).  roX1 and roX2 are both 
transcribed from the X chromosome, and both have a limited ability to attract the MSL 
complex to active genes nearby (Kelley et al., 1999).  Nevertheless, when both roX 
genes are mutated, roX RNA from an autosomal transgene will assemble with the MSL 
proteins, localize to the X chromosome and rescue males (Meller and Rattner, 2002). 
These observations implicate the roX RNAs in correct targeting of the MSL complex to 
the X chromosome.  
How is the X selectively identified? 
The MSL complex is believed to coat the X in a two-step process. Initial MSL 
recruitment is to Chromatin Entry Sites (CES; (Kageyama et al., 2001; Kelley et al., 
1999)). These are functionally identified X-linked sites with the ability to recruit residual 
MSL proteins in msl3 mutants (Fagegaltier and Baker, 2004).  The MSL complex 
spreads from CES into nearby, active genes (Larschan et al., 2007).  High resolution 
binding studies reveal that the MSL complex binds in the body and 3' end of actively 
transcribed genes (Alekseyenko et al., 2006). This pattern corresponds to the co-
transcriptional H3K36me3 mark, which is bound by the MSL3 chromodomain (Larschan 
et al., 2011; Sural et al., 2008).  Enrichment of the MSL complex and H4K16ac towards 
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the 3' end of genes suggests that transcriptional elongation could be facilitated, 
irrespective of the strength of promoter, an idea supported by gene run-on sequencing 
(GRO-seq) studies (Larschan et al., 2011; Smith et al., 2001).  Although this model is 
appealing, other studies report that a modest enrichment of MSL proteins at promoters 
may contribute to activation of X-linked expression (Straub et al., 2013). 
The CES are enriched for MSL Recognition Elements (MREs), 21 bp GA-rich 
motif (Alekseyenko et al., 2008; Straub et al., 2008).  Chromatin-Linked Adaptor for 
MSL Protein (CLAMP), a zinc finger protein that binds the MRE, recruits the MSL 
complex by direct interaction with at least one molecule in this complex (Soruco et al., 
2013).  The MSL2 protein is reported to also directly interact with DNA at a subset of 
CES (Ramirez et al., 2015; Villa et al., 2016).  Cooperation by CLAMP and MSL2 is 
thought to govern the properties of a subset of CES.  In addition, CLAMP promotes 
chromatin accessibility at a distance from sites to which it is bound, and can achieve 
this in the absence of the MSL complex (Urban et al., 2017). Although CLAMP is a 
central factor in MSL complex recruitment, CLAMP binding cannot identify X chromatin.  
For example, CLAMP binds MREs throughout the genome, but only recruits the MSL 
complex to X-linked CES (Soruco et al., 2013).  Indeed, MREs are only two-fold 
enriched on the X-chromosome (Alekseyenko et al., 2008). Additional factors must 
therefore contribute to X recognition.  
Both roX genes are located on the X chromosome, and both have a limited ability 
to recruit the MSL complex in cis (reviewed in (Koya and Meller, 2011)) Additionally, 
both roX genes overlap CES (Alekseyenko et al., 2008; Kelley et al., 1999; Straub et al., 
2008). However, when both roX genes are mutated, an autosomal roX transgene is able 
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to rescue male survival and restore dosage compensation on the X chromosome, 
suggesting that roX RNA is capable of action in trans to the chromatin that is modified 
(Meller and Rattner, 2002; Park et al., 2002).  This reveals that the roX genes do not 
mark the X chromosome.  
Role of siRNA pathway in X identification 
The signature defect of roX1 roX2 mutants is failure of exclusive X-chromosome 
recognition.  A series of observations in our laboratory lead us to suspect that small 
RNA might cooperate with the roX RNAs in X recognition, and, in accord with this idea, 
we discovered that several genes in the siRNA pathway interact genetically with roX1 
roX2 mutants (Menon and Meller, 2009; Menon and Meller, 2012). These studies 
utilized the partial loss of function roX1ex33roX2∆ mutant, which permits ~20% male 
escapers and is thus a sensitive genetic background for identification of genetic 
interactions. The initial study revealed that flies mutated for one copy of the endo-
siRNA components Dcr2, Ago2, D-elp1, or Loqs display enhanced roX1 roX2 lethality 
(Menon and Meller, 2012).  Lethality was accompanied by reduced MSL localization on 
the X-chromosome, suggesting cooperation between siRNA and the MSL complex 
during identification of X chromatin.  While these findings suggested that siRNA 
contributes to X-chromosome recognition during dosage compensation, extensive 
proteomic analyses of siRNA proteins and MSL complex by others have failed to find 
direct interactions between these pathways (Wang et al., 2013).  This led us to propose 
that the role of siRNA in X recognition is likely to be indirect.   
In Drosophila, siRNA processing depends on the source of RNA.  Endogenous 
siRNAs (endo-siRNAs) are processed by Dcr-2 and R2D2, and loaded onto Ago2-
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containing RNAi Induced Silencing Complex (RISC).  RISC recognizes and degrades 
complementary mRNA.  A subset of endo-siRNAs originating from structured loci are 
processed by Dcr-2 and the Loquacious (Loqs) isoform PD (Zhou et al., 2009).  Dcr-2 
associates with D-elp1, which may function in siRNA synthesis (Lipardi and Paterson, 
2009).  Mutations in Dcr2, Ago2, Loqs and D-elp1 all enhance roX1 roX2 male lethality, 
demonstrating a role for siRNA production in dosage compensation. Loss of Ago2 
further reduces X-localization of the MSL proteins in a roX1 roX2 mutant background, 
suggesting that siRNA might help identify X chromatin (Menon and Meller, 2012).   
In considering how the siRNA pathway might promote X recognition in the fly, it 
may be helpful to consider how this pathway modulates chromatin in other organisms. 
siRNA-associated heterochromatin formation in fission yeast involves the RNAi Induced 
Transcriptional Silencing (RITS) complex.  The RITS complex consists of Chp1 (a 
chromodomain protein), Ago1 (equivalent to Drosophila Ago2) and Tas3 (Partridge et 
al., 2000).  siRNA bound by Ago1 recruits the RITS complex to nascent RNA, where it 
acts in cis to promote RNA interference-mediated transcriptional and post-
transcriptional silencing (Sugiyama et al., 2005).  Chp1 requires the methyltransferase 
Clr4, which deposits the H3K9 methylation mark, for localization to chromatin (Verdel et 
al., 2004).  We hypothesize that a RITS-like complex could localize to and modify critical 
sequences on the fly X chromosome, and that this modification could in some way 
promote X recognition by the MSL complex.   
Involvement of the siRNA pathway raised the question of what small RNAs were 
active in dosage compensation. The euchromatin of the fly X-chromosome is enriched 
for a clade of related 1.688X repeats, also known as 1.688 g/cm3 satellite repeats for 
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their density in CsCl gradients, or 359 bp repeats, the typical repeat unit length. The 
1.688X repeats are A-T rich and usually present in short, tandem arrays of 1 to 5 
repeats.  1.688X repeats at different cytological positions share an average 73% identity, 
but individual repeats within a cluster are near-identical.   Specific clusters are denoted by 
a superscript denoting cytological position (Menon et al., 2014).  Kuhn et al., (2012) 
noted the localization of these repeats close to or within genes, and suggested that they 
could play a regulatory role. The X chromosome is strikingly enriched for the 1.688X 
repeats suggesting a potential role in dosage compensation (DiBartolomeis et al., 1992; 
Hsieh and Brutlag, 1979; Waring and Pollack, 1987). Interestingly, many of the 1.688X 
repeats are transcribed, and siRNA corresponding to them has been identified in 
embryos (Menon et al., 2014; Usakin et al., 2007).  To determine if this siRNA is active 
in dosage compensation, Menon et al. (2014) examined the effects of long single 
stranded RNA (ssRNA) and hairpin RNA (hpRNA) from 1.688X repeats on partial loss of 
function roX1 roX2 mutant males. Sense or antisense long ssRNA 1.688X RNA 
decreased male survival by 40-70%, but hpRNA from the 1.6883F repeat, which is 
processed into short siRNA, dramatically enhanced male survival and partially restored 
MSL localization on the X-chromosome (Menon et al., 2014).  These findings led to the 
hypothesis that the siRNA pathway and the repeats on the X-chromosome are involved 
in X-recognition.  
As the X chromosome is enriched with thousands of related 1.688X repeats, as 
well as hundreds of CES, a level of redundancy exists that makes it impractical to study 
the role of an element by deletion.  To determine functionality, autosomal insertions of 
1.688X DNA were created. These autosomal transgenes were able to recruit the MSL 
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complex to nearby chromatin, resulting in functional dosage compensation of nearby 
autosomal genes (Joshi and Meller, 2017). Compensation was enhanced by ectopic 
expression of cognate siRNA.  This study demonstrated that the 1.688X repeats are cis-
acting regulatory sequences that help identify the X chromosome.  How the 1.688X 
repeats accomplish this remains unknown.  We pursued the hypothesis that chromatin 
at 1.688X repeats is modified by a siRNA-dependent mechanism, linking the 1.688X 
repeats and the siRNA pathway to X-recognition. 
Epigenetic modification of 1.688X repeats 
The objective of my dissertation was to test whether the 1.688X repeats are 
targets of siRNA-directed chromatin modification. As no RNAi components have been 
found to interact directly with the MSL complex, siRNA may influence X-recognition by 
an indirect and novel mechanism. For example, Ago2-containing complexes could bind 
nascent RNAs from the X chromosome and recruit activities that alter chromatin 
structure or biochemistry.  These modifications might, in turn, facilitate MSL recruitment 
and spreading into X chromatin. To explore this model, I performed a genetic screen 
that revealed that mutations of numerous genes encoding proteins that physically 
interact with Ago2 enhance the male lethality of roX1 roX2 mutants, and thus are likely 
to participate in dosage compensation. This included the histone methyltransferase 
Su(var)3-9.  I hypothesize that the 1.688X repeats are enriched in H3K9me2 through a 
siRNA-dependent mechanism.  I tested this by chromatin immunoprecipitation (ChIP), 
and found that some 1.688X repeats are indeed sites of H3K9me2 enrichment, and this 
mark is disrupted by ectopic 1.6883F siRNA production.  Similar disruptions are 
observed in chromatin surrounding autosomal insertions of X-linked repeats. I 
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demonstrated that Su(var)3-9 is the enzyme that deposits the H3K9me2 mark on, and 
near, 1.688X repeats.  Finally, genes near autosomal 1.688X insertions increase in 
expression in male larvae, and this increase is further elevated by ectopic 1.6883F 
siRNA.  These findings strongly support the hypothesis that the siRNA pathway is 
responsible for modifying chromatin near 1.688X repeats, and that these modifications 
contribute to recruitment of the MSL complex.  These studies are included in Chapter 3, 
a version of which has been submitted for publication.  
Repetitive sequences have a remarkable relationship with X recognition. The 
MREs themselves have arisen from a mobile element that has expanded across the X 
chromosome (Ellison and Bachtrog, 2013).  The X chromosomes of a number of closely 
related Drosophilids are strikingly enriched for chromosome-specific repeats, and neo-X 
chromosomes rapidly acquire enrichment of X-linked repeats (Gallach, 2014). In 
Chapter 2, I discuss the role of repeats in speciation and development of dosage 
compensation (Deshpande and Meller, 2014).  In Chapter 4, I discuss the implications 
of my findings, present key questions that these studies have raised and summarize 
perspectives for future studies.  
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CHAPTER 2 SEX CHROMOSOME EVOLUTION: LIFE, DEATH AND REPETITIVE 
DNA 
 
This chapter has been published as a review: Sex chromosome evolution: Life, 
death and repetitive DNA, Deshpande N. and Meller V.H., Fly (AUSTIN). 2014; 8, 197-
199 
ABSTRACT 
Dimorphic sex chromosomes create problems.  Males of many species, including 
Drosophila, are heterogametic, with dissimilar X and Y chromosomes.  The essential 
process of dosage compensation modulates the expression of X-linked genes in one 
sex to maintain a constant ratio of X to autosomal expression.  This involves the 
regulation of hundreds of dissimilar genes whose only shared property is a situation 
close to each other on a chromosome.  Drosophila males dosage compensate by up 
regulating X-linked genes two fold.  This is achieved by the Male Specific Lethal (MSL) 
complex, which is recruited to genes on the X chromosome and modifies chromatin to 
increase expression.  How the MSL complex is restricted to X-linked genes remains 
unknown.   Recent studies of sex chromosome evolution have identified a central role 
for two types of repetitive elements in X recognition.  Helitrons carrying sites that recruit 
the MSL complex have expanded across the X chromosome in at least one Drosophila 
species (Ellison and Bachtrog, 2013).  Our laboratory found that siRNA from an X-linked 
satellite repeat promotes X recognition by a yet unknown mechanism (Menon et al., 
2014).  The recurring adoption of repetitive elements as X-identify elements suggests 
that the large and mysterious fraction of the genome called “junk” DNA is actually 
instrumental in the evolution of sex chromosomes.     
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Many eukaryotes determine sex with dimorphic sex chromosomes, such as X 
and Y.  Y chromosomes have dramatically diminished coding potential, and this 
produces problems for the organisms that carry them (Charlesworth, 1996). 
Recombination between the X and Y produces abnormal chromosomes, and must 
therefore be suppressed in the male germ line.  In addition, the somatic expression of 
X-linked genes must be adjusted so that males and females have equivalent levels of 
most proteins encoded on the X.  Mechanisms that recognize and modulate expression 
from the X chromosome, termed dosage compensation, have arisen numerous times 
(Lucchesi and Kuroda, 2015).  The diverse epigenetic machinery that has been 
recruited for this purpose is the subject of many excellent reviews (Lucchesi and 
Kuroda, 2015; Samata and Akhtar, 2018).  But systems of compensation share 
something remarkable and less well understood:  the ability to coordinate modulation of 
nearly all the genes on a single chromosome.  We use an evolutionary perspective to 
argue that mobile elements and repetitive DNA are determinants of X chromosome 
identity in flies.  New studies from our laboratory and others now implicate different 
types of repetitive DNA in recruitment of dosage compensation to the fly X 
chromosome.  Interestingly, mobile elements are also a destructive force in sex 
chromosome evolution.  The non-recombining Y chromosomes are havens for mobile 
DNA, leading to rapid erosion of coding potential (Rice, 1996).  The duality of these 
roles suggests that repetitive sequences underlie the evolutionary plasticity of fly sex 
chromosomes.  
D. melanogaster, and related species, achieves dosage compensation by 
increasing transcription from the male X chromosome approximately two-fold. This 
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occurs by selective recruitment of a ribonucleoprotein complex, the Male Specific Lethal 
(MSL) complex, to transcribed X-linked genes (Alekseyenko et al., 2006).  The MSL 
complex acetylates H4 on lysine 16 (H4K16Ac), a modification that facilitates 
transcriptional elongation, and possibly initiation (Kind et al., 2008; Larschan et al., 
2011).  While the action of the MSL complex on chromatin is well studied, what limits 
the complex to the X chromosome remains unclear.  A group of X-linked sites termed 
Chromatin Entry Sites (CES) recruits the MSL complex, which then moves into nearby 
transcribed genes (Alekseyenko et al., 2008).  CES contain a 21 bp MSL Recognition 
Element (MRE) that binds a protein called CLAMP (Soruco et al., 2013). Knock down of 
CLAMP blocks X chromosome binding of MSL proteins, demonstrating its importance 
for X recognition.  However, MREs are only modestly enriched on the X chromosome. 
Furthermore, CLAMP binds autosomal MREs but fails to recruit MSL proteins to 
autosomal sites. The question of what enables the MSL complex to selectively bind X 
chromatin remains open.   
Comparative studies of repetitive DNA in the Drosophila species group reveals 
enrichment of different types of repetitive DNA on the X chromosome, and this occurs in 
parallel to the acquisition of dosage compensation. D. miranda provides a fascinating 
model as it has three X chromosomes of different ages and uses MREs to attract the 
MSL complex (Alekseyenko et al., 2013). The youngest X chromosomes were produced 
by fusions between autosomes and sex chromosomes (Steinemann et al., 1996). 
Orthologous to the D. melanogaster X is the D. miranda XL, over 60 million years old 
(Tamura et al., 2004).  The D. miranda XR is 15 million years old, and the neo-X 
chromosome is 1 million years old (Bachtrog and Charlesworth, 2002). The neo-X 
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chromosome of D. miranda is in the process of acquiring MREs and enrichment for 
H4K16Ac in males, but this process is near-complete on the XR (Bone and Kuroda, 
1996; Ellison and Bachtrog, 2013). Astonishingly, half of existing MREs on the neo-X 
are found in a transposable element called ISX (Ellison and Bachtrog, 2013). ISX arose 
by mutation of an existing helitron, and subsequent expansion of this element on the 
neo-X.  Furthermore, some MREs on the older XR originated from a different helitron, 
ISXR, which also suffered a mutation that enabled MSL complex recruitment.  While this 
is compelling, the example of D. melanogaster suggests that MREs are not the sole 
element that ensures selective recruitment of dosage compensation. 
Our laboratory previously demonstrated that mutations in the siRNA (small 
interfering RNA) pathway are potent enhancers of mutations that impair X recognition 
during dosage compensation in D. melanogaster males (Menon and Meller, 2012).  This 
was exciting because many organisms modify chromatin using the siRNA pathway. In 
brief, double stranded RNA from bidirectional transcription is processed into siRNA.  
siRNA associates with Argonaute proteins, which in turn guide chromatin-modifying 
complexes to nascent RNAs with identity to the siRNA (Ghildiyal and Zamore, 2009). 
However, no physical interactions between the MSL complex and components of the 
siRNA pathway have been discovered, suggesting an indirect mode of action.  As many 
repetitive sequences are transcribed from both strands, these became candidates for 
the source of chromosome-specific siRNAs.     
Our attention was attracted by a family of satellite repeats that is near-exclusive 
to the D. melanogaster X chromosome and produces siRNA.  The 1.688 g/cm3 repeats 
(1.688X repeats) are dispersed throughout X euchromatin in short, tandem clusters 
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(Menon et al., 2014).  Unusual for repetitive elements, 1.688X repeats are enriched in 
active regions, often in introns (Kuhn et al., 2012). A role in directing dosage 
compensation to the X chromosome would fulfill this prediction. This inspired the 
suggestion that the 1.688X repeats could serve to modulate expression (Kuhn et al., 
2012).  Examination of chromosome-specific repeats in several species revealed that X 
chromosome enrichment for repetitive satellites is strikingly conserved in Drosophila 
species, even when the precise sequence of these repeats is not (Gallach, 2014; 
Menon et al., 2014).  Furthermore, the neo-X chromosome of D. pseudoobscura (similar 
to the XR chromosome of D. miranda) has acquired 1.688X repeats, but the autosomes 
are devoid of them (Gallach, 2014).  
Could the D. melanogaster 1.688X repeats produce a chromosome-specific 
siRNA that helps identify X chromatin? To address this question, long single stranded 
RNA and double stranded RNA was ectopically expressed in flies with moderately 
reduced male survival due to impaired X recognition.  Single stranded 1.688X RNA 
further reduced male survival, but double stranded RNA from one 1.688X repeat 
dramatically rescued males and partially restored MSL localization to the X-
chromosome (Menon et al., 2014).  Based on this, we put forth a model in which siRNA 
produced from 1.688X repeats serves to recruit potential chromatin modifiers to similar 
X-linked regions.  Rather than recruiting the MSL complex directly, we postulate that 
alteration of chromatin at 1.688X repeats allows the X chromosome to assume a 
characteristic interphase conformation that facilitates recognition or distribution of the 
MSL complex along the chromosome.  In support of this idea, the X chromosome 
assumes different conformations in the interphase nuclei of males and females 
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(Grimaud and Becker, 2009).  Although our studies focused on Drosophila, one of the 
major classes of mammalian repetitive DNA has long been suspected to play a role in 
dosage compensation. Mammals dosage compensate by inactivating a single X 
chromosome in females (Disteche, 2012).  Long Interspersed Nuclear Elements 1 (L1 
elements) are enriched on the mammalian X and have been proposed to assist 
recognition of X chromatin, or spreading of silencing, during X-inactivation in mammals 
(Lyon, 2006).  Interestingly, the formation of the inactive X territory during early 
differentiation is coincident with a burst of siRNA production by the L1 elements (Chow 
et al., 2010).  We postulate that in both flies and mammals the challenge of selectively 
recognizing an entire chromosome is met with a combination of collaborating epigenetic 
pathways.    
These findings raise several intriguing questions.  Do X-enriched satellite repeats 
in other Drosophila species produce siRNA that promotes X recognition?  If so, the 
rapid turnover of these repeats may be a factor in hybrid incompatibilities, which 
preferentially effect males, sometimes disrupting dosage compensation (Barbash, 
2010).  Interestingly, at least 10 Mb of pericentric X heterochromatin is composed of 
similar 1.688X repeats in D. melanogaster, but absent in related species (Lohe et al., 
1993).  When hybrid matings introduce the D. melanogaster X chromosome into D. 
simulans ooplasm, the heterochromatin of the D. melanogaster X fails to resolve during 
early mitotic divisions, causing hybrid female lethality (Ferree and Barbash, 2009).  One 
possible explanation is that D. simulans oocytes lack the abundant 1.688X small RNAs, 
which may be necessary to initiate formation of pericentromeric heterochromatin at the 
1.688X repeats.  Consistent with these ideas, removal of nearly all D. melanogaster X 
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heterochromatin by the Zhr1 translocation rescues mitosis in hybrid females (Ferree and 
Barbash, 2009).  These studies suggest that a single, rapidly evolving class of repetitive 
sequences on the fly X chromosome intersects with sex chromosome biology in ways 
that critically influence viability and reproduction.  
Eukaryotic genomes are rich with repetitive elements, often referred to as junk 
DNA, that have few known functions.  Recent studies reveal that chromosome-specific 
repetitive elements and small RNA based chromatin regulation have been repeatedly 
adapted to guide epigenetic regulation of a chromosome.  The ability to direct dosage 
compensation to an entire linkage group is an essential step in the evolution of 
dimorphic sex chromosomes.  As repetitive sequences are also implicated in hybrid 
incompatibilities, we postulate that they confer “evolvability” not only on the 
predecessors of highly differentiated sex chromosomes, but also contribute to the 
development of species.   
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CHAPTER 3 CHROMATIN AT X-LINKED REPEATS THAT GUIDE DOSAGE 
COMPENSATION IN DROSOPHILA MELANOGASTER IS MODULATED BY THE 
SIRNA PATHWAY 
 
A version of this chapter is submitted to Genetics (DESHPANDE N. and 
MELLER V.H., submitted) 
Abstract 
Many heterogametic organisms adjust sex chromosome expression to 
accommodate differences in gene dosage.  This requires selective recruitment of 
regulatory factors to the modulated chromosome.  How these factors are localized to a 
chromosome with requisite accuracy is poorly understood.  Drosophila melanogaster 
males increase expression from their single X chromosome.  Identification of this 
chromosome involves cooperation between different classes of X-identity elements.  
The Chromatin Entry Sites (CES) recruit a chromatin-modifying complex that spreads 
into nearby genes and increases expression.  In addition, a family of satellite repeats 
that is enriched on the X chromosome, the 1.688X repeats, promotes recruitment of the 
complex to nearby genes.  The 1.688X repeats and CES are dissimilar, and appear to 
operate through different mechanisms.  Interestingly, the siRNA pathway and siRNA 
from a 1.688X repeat also promote X recognition.  We postulate that siRNA-dependent 
modification of 1.688X chromatin contributes to recognition of nearby genes.  In accord 
with this, we found enrichment of the siRNA effector Argonaute2 (Ago2) at some 1.688X 
repeats.  Mutations in several proteins that physically interact with Ago2, including the 
histone methyltransferase Su(var)3-9, enhance the lethality of males with defective X 
recognition.  Su(var)3-9 deposits H3K9me2 on some 1.688X repeats, and this mark is 
disrupted upon ectopic expression of 1.688X siRNA.  Furthermore, integration of 1.688X 
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DNA on an autosome induces H3K9me2 deposition in nearby chromatin and enhances 
expression of genes on either side up to 140kb away, in a siRNA-dependent manner.  
Our findings are consistent with a model in which siRNA-directed modification of 1.688X 
chromatin contributes to identification of the fly X chromosome. 
Introduction 
Males of many species carry one X chromosome and a gene-poor Y 
chromosome.  Hemizygosity of the male X chromosome produces a potentially lethal 
imbalance in the ratio of X to autosomal gene products.  This imbalance is corrected by 
a process known as dosage compensation, a specialized type of gene regulation that 
modulates expression of an entire chromosome.  Different strategies to achieve dosage 
compensation have evolved independently. In Drosophila melanogaster, males increase 
X-linked gene expression by approximately two-fold (Lucchesi and Kuroda, 2015).  This 
involves the activity of the Male Specific Lethal (MSL) complex.  The MSL complex is 
recruited to active genes on the X chromosome, where it modifies chromatin to increase 
expression (Lucchesi and Kuroda, 2015).  The MSL complex contains five proteins, 
Male-Specific Lethal 1, -2, and -3 (MSL1, -2, -3), Maleless (MLE), and Males Absent on 
the First (MOF) (reviewed in (Koya and Meller, 2011)).  Enhanced transcription by the 
MSL complex is associated with H4K16 acetylation by MOF (Akhtar and Becker, 2000; 
Smith et al., 2000).  H4K16 acetylation decondenses chromatin, and this may enhance 
transcriptional elongation of X-linked genes (Larschan et al., 2011; Shogren-Knaak et 
al., 2006).  
The MSL complex also contains one of two non-coding RNA on the X (roX1, -2) 
transcripts (Quinn et al., 2014).  While elimination of any one of the MSL proteins is 
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lethal to males, roX1 and roX2 are redundant for compensation.  Mutation of both roX 
genes leads to mislocalization of the MSL proteins to ectopic autosomal sites in male 
larvae (Deng and Meller, 2006; Meller and Rattner, 2002).  X-linked gene expression is 
reduced in these males, as is survival to adulthood.  Both roX genes are located on the 
X chromosome, and both overlap Chromatin Entry Sites (CES), specialized sites with 
increased affinity for the MSL complex (Alekseyenko et al., 2008; Kelley et al., 1999; 
Straub et al., 2008).   
Although much is known about the role of MSL complex in dosage 
compensation, how this complex selectively targets the X chromosome is poorly 
understood.  Recognition and binding to X chromatin is believed to be a two-step 
process.  Initial recruitment of the MSL complex to CES is followed by spreading into 
nearby transcribed genes (Gelbart and Kuroda, 2009). Contained within the CES are 
motifs called MSL Recognition Elements (MREs) (Alekseyenko et al., 2008; Straub et 
al., 2008). MREs are 21 bp GA-rich motifs that bind Chromatin-Linked Adaptor for MSL 
Protein (CLAMP), a zinc finger protein that is essential for MSL recruitment (Soruco et 
al., 2013). Spreading into nearby active genes is supported by interaction of MSL3 with 
the cotranscriptional H3K36me3 mark (Kind and Akhtar, 2007; Larschan et al., 2007; 
Sural et al., 2008).  These mechanisms describe local recruitment of the MSL complex, 
but fail to explain how the MSL complex specifically targets the X-chromosome.  
H3K36me3 is enriched on active genes throughout the genome. MREs are only 
modestly enriched on the X chromosome which contains 167.7 copies of MREs per Mb 
compared to autosomes that contain 92.3 copies per Mb. Furthermore, CLAMP binds 
MREs throughout the genome, but only recruits the MSL complex to X-linked CES 
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(Alekseyenko et al., 2008; Soruco et al., 2013).  We conclude that additional 
mechanisms must distinguish X and autosomal chromatin.  
X-localization is disrupted in roX1 roX2 males, making them a sensitized genetic 
background that can be used to identify additional factors contributing to X recognition.  
Using this strategy, our laboratory demonstrated a role for the siRNA pathway in 
recognition of the X-chromosome (Menon et al., 2014; Menon and Meller, 2012).  A 
likely source of siRNA is a family of repeats that is near exclusive to the X chromosome.  
These are the AT rich, 359 bp 1.688X satellite repeats, a clade of which is found in 
short, tandem arrays throughout X euchromatin (DiBartolomeis et al., 1992; Gallach, 
2014; Hsieh and Brutlag, 1979; Waring and Pollack, 1987).  Specific clusters are 
denoted by a superscript indicating cytological position.  In support of this idea, ectopic 
production of siRNA from one 1.688X repeat partially rescues roX1 roX2 males (Menon 
et al., 2014).  1.688X repeats are often close to or within genes, leading to the idea that 
they function as “tuning knobs” for gene regulation (Kuhn et al., 2012).  In accord with 
these ideas, autosomal insertions of 1.688X DNA enable recruitment of functional 
dosage compensation to nearby autosomal genes (Joshi and Meller, 2017). 
The 1.688X repeats share no sequence identity with the CES, and appear to act 
in a genetically distinct manner (Joshi and Meller, 2017).  The question of how 1.688X 
DNA promotes compensation of nearby genes is thus of great interest.  We pursued the 
idea that siRNA-directed modifications of chromatin at 1.688X repeats link the repeats 
and the siRNA pathway to X recognition. Reduction of the siRNA-binding effector 
protein Argonaute 2 (Ago2) enhances the lethality of partial loss of function roX1 roX2 
mutations, and further reduces X-localization of MSL proteins (Menon and Meller, 
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2012).  We hypothesized that an Ago2-containing complex might localize to and modify 
chromatin.  In accord with this idea, we find that Ago2 is enriched at 1.688X repeats.  
Proteins interacting with Ago2 may also play a role in dosage compensation.  To 
address this, we tested high confidence Ago2-binding proteins for genetic interactions 
with roX1 roX2, and found that mutations in several of these genes further reduced roX1 
roX2 male survival.  Of particular interest is the H3K9 methyltransferase, Su(var)3-9, 
which is responsible for enrichment of H3K9me2 at a subset of 1.688X repeats.  
H3K9me2 enrichment is disrupted upon ectopic expression of 1.688X siRNA.  
Chromatin flanking an autosomal insertion of 1.688X DNA is enriched for H3K9me2, and 
enrichment is enhanced by ectopic expression of 1.688X siRNA.  Expression of 
autosomal genes near the 1.688X transgene is increased in male larvae, and further 
elevated by ectopic production of 1.688X siRNA. These findings support the idea that 
siRNA-dependent modification of chromatin in or near 1.688X repeats contributes to X 
recognition during dosage compensation.  We propose that epigenetic modifications link 
the siRNA pathway, 1.688X repeats on the X chromosome and X recognition.   
Materials and Methods 
Fly culture and Genetics 
Mutations Dcr1Q1147X, Rm6201086, Fmr1Δ113m, Su(var)3-91, Su(var)3-92, smg1, 
Taf111, Taf115, p535A-1-4, p5311-1B-1, foxoΔ94, PIG-Se00272, belL4740, bel6, barrL305, 
SmD1EY01516, vigC274, Ago1k08121, aubQC42, piwi06843, Su(var)2-102, eggMB00702, G9aMB11975, 
P{EPgy2}09821, P{EPgy2}15840, Ago2414 and FLAG.HA.Ago2 were obtained from the 
Bloomington Drosophila Stock Center.  Su(var)3-714 was a gift from Dr. P. Spierer 
(Seum et al., 2002). ocm166 was a gift from Dr. R. Kelly.  ΔDsRedΔupSET (upSET in 
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Figure 3.4) was a gift from Dr. M. Kuroda (McElroy et al., 2017).  All mutations were out 
crossed for five generations to minimize the effect of genetic background.  Balanced 
stocks were constructed with outcrossed chromosomes and a laboratory reference Y-
chromosome (Menon and Meller, 2009).  All mutations were confirmed by phenotype or 
PCR.  Each test scored about 1000 flies and was performed in triplicate.  To express 
1.6883F siRNA in a Su(var)3-9-/- mutant background, we generated  [hp1.6883F] [Sqh-
Gal4]/In(2LR)Gla wgGla-1; Su(var)3-91/ TM3TbSb flies and selected non-Tb third instar 
males for ChIP.  The [Sqh-Gal4] insertion was a gift of Dr. S. Todi. 
Tissue collection and chromatin preparation 
Embryo collection and chromatin preparation was as previously described (Koya 
and Meller, 2015).  Briefly, 0.5 g of 0 - 12 hr embryos were collected on molasses plates 
with yeast.  Embryos were dechorionated for 2.5 min in bleach, crosslinked in 50 mM 
HEPES, 1 mM EDTA, 0.5 mM EGTA, 100 mM NaCl, 1 % formaldehyde with heptane for 
20 min.  Crosslinking was quenched with 125 mM glycine, 0.01 % Triton X-100, 1 X 
PBS for 30 min. Embryos were washed with 10 mM HEPES, 200 mM NaCl, 1 mM 
EDTA, 0.5 mM EGTA and 0.01 % Triton X-100 and suspended in 10 mM HEPES, 1 mM 
EDTA, 0.5 mM EGTA, 0.1 % Na-deoxycholate and 0.02 % Na-azide for sonication in 
2.5 ml buffer.  Sonication was performed on ice at 35 % amplitude, 30 sec on, 59 sec off 
for a total time 15 min using a Fischer Scientific Model FB505 sonicator and produced 
300-600 bp fragments.  Chromatin was clarified by centrifuging at 13,000 rpm for 15 
min, diluted 1:1 with 2 X RIPA buffer (2 % Triton X-100, 0.2 % Na-deoxycholate, 0.2 % 
SDS, 280 mM NaCl, 20 mM Tris-HCl pH 8.0, 2 mM EDTA, 0.02 % Na-azide, 2 mM 
DMSF with complete protease inhibitor (Roche)).  Chromatin solution (5.5 ml) was 
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preabsorbed by incubation at 4˚C for 30 min with 55 µl of blocked PierceTM Protein A 
agarose beads (Catalog #20333) and aliquots stored at -80˚C.  
For larval chromatin, a modified protocol from (Kuzu et al., 2016) was used.  150 
larvae were frozen in liquid N2 and ground in a chilled mortar.  The powder was 
transferred to a cooled 15 ml Dounce and homogenized with a loose pestle (10 strokes) 
and a tight pestle (15 strokes) in 10 ml PBS with protease inhibitor.  Homogenate was 
made to 40 ml with PBS, crosslinked with 1 % formaldehyde for 20 min and quenched 
with 125 mM glycine for 30 mins.  Crosslinked material was pelleted, washed once with 
wash buffer A (10 mM Hepes pH 7.6, 10 mM EDTA, 0.5 mM EGTA, 0.25 % Triton X-
100, protease inhibitor and 0.2 mM PMSF), once with wash buffer B (10 mM Hepes pH 
7.6, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 1 % Triton X-100, protease inhibitor 
and 0.2 mM PMSF), and 3 times with TE wash buffer (10 mM Tris pH 8.0, 1 mM EDTA, 
0.01 % SDS, protease inhibitor and 0.2 mM PMSF).  The pellet was resuspended in 2 
ml pre-RIPA buffer (0.1 % SDS, 10 mM Tris-HCl, 1 mM EDTA, protease inhibitor and 
0.2 mM PMSF).  Sonication was performed at settings described above for 2 min.  
Sonicated samples were diluted with 1 % Triton X-100, 0.1 % Na-deoxycholate, and 
140 mM NaCl, centrifuged at 1500 g to clarify, aliquoted and stored at -80˚C.  
Chromatin Immunoprecipitation  
Seventy five micrograms of chromatin was incubated overnight with 4 µl anti-
H3K9me2 (4 µg, Abcam, ab1220) or 8 µl anti-H3K9me3 (8 µg, Abcam, ab8898) at 4˚C, 
clarified by centrifugation at 14,000 rpm for 5 min and supernatants transferred to tubes 
containing 40 µl blocked PierceTM Protein A agarose beads (Catalog #20333) and 
incubated 4 h at 4˚C.  Washing, reverse crosslinking, DNA isolation and qPCR analysis 
24 
 
 
was as previously described (Koya and Meller, 2015).  ChIP primers are presented in 
Appendix H.   
Protein Isolation from embryos 
Fifty mg of 0 - 12 hr embryos were homogenized in 250 µl RIPA buffer on 
ice. Homogenate was passed through a 26 gauge needle 10 - 12 times to shear 
DNA. Particulate matter was removed by centrifugation, and supernatant was mixed 
with an equal volume of 2 X SDS Sample buffer and boiled for 5 min before separation 
on a 15 % SDS polyacrylamide gel.  
Protein blotting 
Polyacrylamide gels were equilibrated in transfer buffer (48 mM Tris, 39 mM 
glycine, 1.3 mM SDS, 20 % methanol) for 20 min.  A PVDF membrane was activated in 
100 % methanol for 1 min.  Filter paper and activated PVDF membranes were saturated 
in transfer buffer and proteins transferred using a Trans-Blot SD Semi-Dry Transfer Cell 
(BIO-RAD). The membrane was washed in TBST (10 mM Tris-Cl, 200 mM NaCl, 0.1 % 
Tween 20, pH 7.5), blocked in 5 % BSA, washed in TBST and probed overnight at 4˚ 
using 1:2000 mouse anti-H3K9me2 diluted in blocking solution (Abcam, ab1220) or 
1:4000 goat anti-tubulin (Developmental Studies Hydrinoma Bank, E7).  After washing 
with TBST, the membrane was incubated with alkaline phosphatase conjugated 
secondary antibodies (goat anti-mouse, Sigma, A3562 or rabbit anti-goat, Sigma, 
A4062), washed and developed in 100 mM diethanolamine, 100 mM NaCl, 5 mM 
MgCl2, pH 9.5 containing 33 µg/ml Nitroblue Tetrazolium (NBT) and 165 µg/ml 5-Bromo-
4-chloro-3-indolyl phosphate (BCIP).  Signals were quantified by ImageJ.   
Quantitative RT-PCR 
25 
 
 
Total RNA was isolated from 50 third instar male larvae or 100 mg dechorionated 
embryos using Trizol reagent (Invitrogen) as previously described (Koya and Meller, 
2015). One microgram of RNA was reverse-transcribed using random hexamers and 
ImProm-II reverse transcriptase (Promega).  Duplicate reactions were amplified using 
iTaq Universal SYBR Green Supermix (Bio-Rad) with an Mx3000P Real-Time PCR 
system (Stratagene).  Primers are in Appendix H. Values were normalized to dmn 
(DCTN2-p50) and expression calculated using the efficiency corrected comparative 
quantification method (Pfaffl, 2001). 
Results 
Ago2 localizes at 1.688X repeats. 
Ago2 localization was determined using a FLAG-tagged Ago2 transgene that was 
first tested for rescue of the dosage compensation function of Ago2.  Males with the 
partial loss of function roX1ex40roX2Δ chromosome have high survival, as do Ago2-/- 
flies, but synthetic lethality is observed in roX1ex40roX2Δ/Y; Ago2-/- males (Menon and 
Meller, 2012).  One copy of a FLAG-Ago2 transgene rescues these males, 
demonstrating that the FLAG tag does not disrupt the dosage compensation function of 
Ago2 (Figure 3.1, 3.2).  Chromatin from FLAG-Ago2; Ago-/- embryos, and from a 
reference strain lacking the FLAG-Ago2 transgene, was immunoprecipitated with anti-
FLAG antibodies and enrichment determined by quantitative PCR (qPCR).  FLAG-Ago2 
was enriched at the Hsp70 promoter, a site known to bind Ago2 (Cernilogar et al., 2011) 
(Figure 3.3 A).  In contrast, a control region in the dmn gene displayed no enrichment.  
We then examined FLAG-Ago2 enrichment at a panel of six representative 1.688X 
repeats that differ in location, copy number, sequence, genetic environment and 
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transcription level (Table 3.1).  Interestingly, five of these show enrichment of FLAG-
Ago2 over the repeats, but little or no enrichment in flanking regions (Figure 3.3 B).  We 
conclude that Ago2 localizes at many 1.688X repeats, a finding that is consistent with 
involvement of Ago2 in siRNA-directed recruitment of chromatin modification at or 
around these regions. 
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Figure 3.1. Mating scheme to express FLAG-Ago2 in Ago2 mutants. FLAG-Ago2 is 
marked by w+, enabling identification through the multiple crossing steps. roX2Δ is also 
marked by w+. Presence of both, roX2Δ and FLAG-Ago2 results in a darker red eye 
color. 
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Figure.3.2. FLAG-Ago2 rescues the Ago2 dosage compensation function. Ratio of 
test male survival to control male survival is plotted. A FLAG-Ago2 transgene (right) 
rescues the synthetic lethality of roX1ex40 roX2Δ/Y; Ago2414/414 males (center). 
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Repeat 1.6881A 1.6883C 1.6883F 1.6884A 1.6887E 1.6887F 
Cytological position 1A1 3B5 3F3 4A4 7E5 7F3 
 
Scaffold 
coordinates 
on X 
204,046.. 
241,257 
2,768,669.. 
2,770,136 
3,857,647.. 
3,858,186 
4,070,631.. 
4,071,316 
8,369,270.. 
8,369,783 
8,530,749.. 
8,531,260 
C
o
p
y
 n
u
m
b
e
r 
Genomic 
Scaffold 
98 3 2.5 2 1.5 1.5 
Laboratory 
reference 
- 3.5 3.5 2.5 2.5 1.5 
R
e
p
e
a
t 
p
ro
p
e
rt
ie
s
 
Percent 
match to 
1.6883F 
89 69 100 95 71 69 
Genomic 
environment 
37kb of 
repeats 
between 
convergent 
genes 
Intronic 
Between 
convergent 
genes 
Isolated Isolated Intronic 
T
ra
n
s
c
ri
p
ti
o
n
 
EST 
abundance 
0 2 9 2 0 26 
qRT PCRa 0.00026 0.01 0.3 0.1 0.04 1.5 
RNA polII 
enrichment 
- - + - - - 
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Table 3.1. Panel of 1.688X repeats used in this study. Cytological positions of 1.688X 
repeats and scaffold coordinates were determined from Flybase (Release 6). The size 
of some repeat clusters in our laboratory reference strain was found to differ from the 
genomic scaffold.  See Appendix D for determination of copy number. Similarity to 
1.6883F was determined by BLAST.  EST abundance was inferred from assigned ESTs 
in Flybase.  RNA polII enrichment is derived from ChIP-seq of 6-8 h mesoderm (Monfort 
and Furlong, 2015).  a Quantitative RT-PCR (qRT PCR) is normalized to repeat copy 
number (see Figure 3.11). 
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Figure 3.3. FLAG-Ago2 localizes at 1.688X repeats. Chromatin from the laboratory 
reference strain (white) and Ago2414/414; FLAG-Ago2 (black) embryos was precipitated 
with anti-FLAG antibody.  Enrichment normalized to input is shown.  (A) The Hsp70 
promoter displays enrichment, but a control region in dmn does not.  (B) FLAG-Ago2 
enrichment is detected at several 1.688X repeats (gray arrowheads).  Approximately 
100 copies of the 1.6881A repeats are situated between tyn and CG3038.  The 1.6883C 
repeats are within a large kirre intron (splicing indicated by diagonal lines).  Primers 
used for analysis are indexed by gene and amplicon number and presented in Appendix 
H.   Standard error of two biological replicates is shown. 
A 
B 
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Genetic interactions identify an Ago2-interaction network that participates in 
dosage compensation.  
Argonaute proteins in the RNA Induced Transcriptional Silencing (RITS) 
complexes of S. pombe and plants recruit chromatin modifiers to nascent transcripts 
(reviewed in (Meller et al., 2015)).  To explore the possibility of Ago2-interacting proteins 
participating in X chromosome recognition, we screened genes in an Ago2-interaction 
network for genetic interaction with roX1 roX2.  A map of high probability Ago2-
interactors was created using BioGRID (Stark et al., 2006), and esyN (Bean et al., 
2014) (Figure 3.4 A; see Appendix E for inclusion criteria).  Members of this network 
were examined for genetic interactions with the partial loss of function roX1ex33roX2Δ X 
chromosome.  roX1ex33roX2Δ males display partial mislocalization of MSL proteins and 
eclose at 20 % of normal levels (Deng et al., 2005b). Reduction of proteins that 
participate in X recognition further disrupts X localization and enhances roX1ex33roX2Δ 
male lethality (Menon and Meller, 2012).  Females are fully viable and fertile when the 
roX genes are mutated. roX1ex33roX2Δ females were mated to males that were 
heterozygous for a mutation in the gene being tested (Figure 3.5 A). All sons are 
roX1ex33roX2Δ/Y, and heterozygous (experimental) or wild type (control) for the gene of 
interest.  Normalized survival (experimental /control) reveals enhancement of roX1 roX2 
male lethality (Figure 3.4 B, C).  Daughters, which do not dosage compensate and are 
heterozygous for roX1ex33roX2Δ, do not display altered survival upon mutation of Ago2-
interacting genes.  As G9a is located on the X chromosome, a modified strategy to test 
this gene is presented in Figure 3.5 B, C.   
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Normalized survival of roX1ex33roX2Δ males with mutations in the Ago2-
interaction network is presented in Figure 3.4 B.  Genes displaying significant 
interactions are noted by pink symbols, and those showing no interaction are blue in 
Figure 3.4 A.  We confirmed a previously identified siRNA-processing sub-network 
containing Dcr2, Elp1, and loqs (Figure 3.4 A, dotted line; (Menon and Meller, 2012)).  
The present study identified several additional Ago2-interactors, including a potential 
chromatin-modifying sub-network containing Dcr1, Fmr1, Rm62, and the histone 
methyltransferase Su(var)3-9 (green, Figure 3.4 A).  Su(var)3-9 deposits H3K9me2 and 
acts with Rm62 to re-silence active chromatin (Boeke et al., 2011).   
Additional chromatin modifiers and genes in other small RNA pathways were 
also tested (Figure 3.4 C). A previous study found no interaction between roX1ex33roX2Δ 
and the piRNA pathway genes aub and piwi, or the miRNA pathway gene Ago1, a 
finding replicated here.  Since our findings point towards involvement of chromatin 
modifiers, we tested the chromatin regulatory factor Su(var)2-10 and two additional 
H3K9 methyltransferases, eggless (egg) and G9a (Figure 3.4 C).  None of these 
modified roX1ex33roX2Δ survival.  Mutations in Su(var)3-7, important for heterochromatin 
formation, and upSET, which maintains heterochromatin and H3K9me2 levels, enhance 
roX1ex33roX2Δ male lethality (McElroy et al., 2017; Spierer et al., 2008).  Over 
compensating males (ocm) has an unusual dosage compensation phenotype as 
mutations in ocm rescue males with insufficient MSL activity, suggesting that it might act 
as a governor of activation (Lim and Kelley, 2013).  Interestingly, mutation of ocm 
significantly increased the survival of roX1ex33roX2Δ males, supporting the idea that ocm 
normally restrains activation.  The P{EPgy2}09821 and P{EPgy2}15840 strains, used to 
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outcross Su(var)3-9 and barr mutants, display no interaction and serve as controls for 
genetic background.  Taken together, these findings suggest that several genes that 
deposit H3K9me2, maintain this mark or participate in heterochromatin formation also 
contribute to X chromosome dosage compensation.  At first glance these observations 
appear to be at odds with X chromosome hypertranscription, the ultimate consequence 
of X chromosome recognition.  
Ectopically expressed 1.6883F siRNA disrupts H3K9me2 patterns 
Previous studies found that ectopically produced 1.6883F siRNA partially rescues 
roX1 roX2 males and increases X localization of the MSL complex (Menon et al., 2014).  
The mechanism by which siRNA promotes X recognition is unknown.  The discovery 
that insertion of 1.688X DNA on an autosome enables functional compensation of 
nearby genes, and the enhancement of this effect by ectopic 1.6883F siRNA, suggests 
siRNA action through cognate genomic regions (Joshi and Meller, 2017).  In accord with 
this idea, an autosomal roX1 transgene also enables compensation of nearby genes, 
but is unaffected by 1.6883F siRNA.  To test the idea that 1.6883F siRNA directs 
epigenetic modification of 1.688X chromatin, we used ChIP to analyze chromatin around 
1.688X repeats on the X chromosome.  ChIP-qPCR detected H3K9me2 enrichment in 4 
out of 6 repeats (white bars, Figure 3.6).  As H3K9me2 enrichment was not uniform, we 
considered additional factors that might determine this mark, and noted that only 
repeats showing evidence of transcription were enriched for H3K9me2, consistent with 
the idea of Ago2-dependent recruitment to nascent transcripts (Verdel et al., 2004).  
Upon ectopic expression of 1.6883F siRNA a dramatic disruption of H3K9me2 was 
observed in and around 1.688X repeats (black bars, Figure 3.6).  For example, 1.6883F 
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and 1.6884A display peaks of H3K9me2 in wild type flies, but this mark was reduced 
over the repeats and increased in surrounding regions by elevated 1.6883F siRNA.  
Untranscribed repeat clusters at 1.6881A and 1.6887E show no H3K9me2 enrichment in 
wild type flies, but gained H3K9me2 upon expression of 1.6883F siRNA.  In contrast, no 
enrichment of H3K9me3 in or near 1.688X repeats was detected in wild type or 1.6883F 
siRNA-expressing embryos (Figure 3.7). This is as expected as H3K9me2 is found in 
facultative heterochromatin by contrast H3K9me3 is found in constitutive 
heterochromatin such as at telomeres and centromeres (Becker et al., 2016). We 
conclude that some 1.688X repeats are enriched for H3K9me2, and that ectopic 
production of cognate siRNA broadly disrupts this mark.  
Su(var)3-9 deposits H3K9me2 at 1.688X repeats 
The identification of Su(var)3-9 as an indirect binding partner of Ago2, observation of a 
genetic interaction between Su(var)3-9 and roX1 roX2 and enrichment of H3K9me2 on 
some 1.688X repeats suggests that Su(var)3-9 could be modifying 1.688X repeats.  D. 
melanogaster has three histone H3K9 methyltransferase, Su(var)3-9, eggless, and G9a, 
but only Su(var)3-9 mutations enhance the male lethality of roX1 roX2 ((Swaminathan 
et al., 2012); Figure 3.4).  To determine if Su(var)3-9 is responsible for H3K9me2 at 
1.688X chromatin,  3rd instar larvae mutated for Su(var)3-9, or mutated for Su(var)3-9 
and expressing 1.6883F siRNA, were generated (Figure 3.8). H3K9me2 enrichment is 
virtually eliminated over 1.688X repeats in Su(var)3-9-/- mutants (gray bars, Figure 3.9) 
and remains low in Su(var)3-9-/- larvae that express 1.6883F siRNA (black bars, Figure 
3.9).  This reveals that Su(var)3-9 deposits H3K9me2 at 1.688X chromatin in wild type 
flies, and eliminates the possibility that a different methyltransferase is recruited to these 
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regions following ectopic expression of 1.6883F siRNA. Disruption of H3K9me2 upon 
expression of 1.6883F siRNA thus reflects changes in the localization or activity of 
Su(var)3-9. 
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Figure 3.4. Ago2-interactors participate in dosage compensation. (A) Map of 
Ago2-interacting proteins.  Genes displaying a genetic interaction with roX1ex33roX2Δ 
are pink, and those for which a significant interaction has not been detected are blue.  
Genes in gray are untested.  A previously reported siRNA-production sub-network is 
highlighted by the dotted line.  A putative chromatin-modifying sub-network identified in 
the present study is highlighted in green.  Well-curated, high probability interactions 
from BioGRID and esyN are depicted by solid lines.  See Appendix E for inclusion 
criteria. (B) Mutations in many Ago2-interacting proteins reduce the recovery of 
roX1ex33roX2Δ males (black; roX1ex33roX2Δ/Y; mut/+ normalized to roX1ex33roX2Δ/Y; 
+/+).  Females are unaffected (white; roX1ex33roX2Δ/++; mut/+ normalized to 
roX1ex33roX2Δ/++; +/+).  (C) Additional controls and genes of interest.  The mating 
strategy to test X-linked G9a is presented in Figure 3.5 C.  See Materials and Methods 
for upSET description.  SEM is represented by error bars. Significance of ≤0.05 (*) and 
≤0.001 (**) was determined using the Student’s two sample t-test.  
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Figure 3.5. Detection of genetic interactions between roX1 roX2 and candidate 
genes.  (A) roX1ex33roX2Δ females were mated to males heterozygous for a mutation in 
the gene of interest.  The survival of sons mutated for the gene of interest (bottom right) 
is divided by that of control brothers (bottom left) and presented in Figure 3.4 B and C. 
In an otherwise wild type background, roX1ex33roX2Δ allows 20 % adult male escapers.  
Females do not dosage compensate and serve as an internal control. (B) Mating 
scheme to generate G9a roX1ex33roX2Δ mutants. G9a is marked by GFP and roX2Δ is 
marked by w+, enabling identification of recombinants carrying both mutations. 
Recombinants that were also roX1ex33, predicted to be 33.5% of the lines screened, 
were identified by PCR.  G9a roX1ex33roX2Δ recombinant 3 was used in subsequent 
studies. (C) Testing for genetic interaction between G9a and roX1ex33roX2Δ.  
Heterozygous G9aMB1197 roX1ex33roX2Δ/+ roX1ex33roX2Δ females were mated to G9a 
MB1197 roX1 roX2 males.  G9aMB1197 is marked with EGFP.  The survival of G9a MB1197 
roX1ex33roX2Δ sons (EGFP-positive, right) was divided by that of EGFP-negative + 
roX1ex33roX2Δ sons (left).  EGFP intensity differentiates F1 females that are 
homozygous or heterozygous for G9a MB1197. 
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Figure 3.6. Elevated 1.6883F siRNA disrupts H3K9me2 enrichment around 1.688X 
repeats.  Chromatin from wild type embryos (white) and embryos ectopically producing 
1.6883F siRNA (black) was immunoprecipitated with antibody to H3K9me2.  Enrichment 
over input was determined by quantitative PCR (qPCR).  The standard error of two 
biological replicates is shown.  Primers used for analysis are presented in Appendix H. 
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Figure 3.7. H3K9me3 is not enriched over 1.688X repeats or altered by ectopic 
expression of 1.6883F siRNA. Chromatin from 6-12 hr embryos was 
immunoprecipitated with antibody to H3K9me3. DNA was analyzed by qPCR using 
primers within 1.688X repeats (gray triangles) or in flanking regions.  Approximately 100 
copies of 1.6881A are present between tyn and CG3038.  Primers indexed by gene and 
amplicon number are presented in Appendix H.  No significant enrichment within 
repeats, or change in H3K9me3 within repeats, is observed following siRNA expression.  
Standard error is derived from two biological replicates. 
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To determine how far from 1.688X repeats the H3K9me2 disruption extends, 
regions 10-26 kb from repeats were examined. In each case, these regions displayed 
increased H3K9me2 in embryos with ectopic 1.6883F siRNA expression (Figure 3.10 A). 
This suggested the possibility of a global change in H3K9me2.  To address this 
possibility we probed protein blots from wild type and 1.6883F siRNA-expressing 
embryos to determine the levels of this modification.  In spite of apparently wide-spread 
elevation of H3K9me2, no evidence for a global change in H3K9me2 level is detected 
(Figure 3.10 B).  As most H3K9me2 is found in heterochromatic regions that comprise 
~30% of the fly genome, changes in euchromatic regions may represent a negligible 
portion of the nuclear pool. 
H3K9me2 is generally thought to be repressive, but compensation in flies occurs 
by increased expression of X-linked genes.  To determine if changes in H3K9me2 
enrichment correlate with changes in transcription, expression of genes near 1.688X 
repeats was examined in wild type and 1.6883F siRNA-expressing embryos.  Consistent 
with H3K9me2 having a repressive effect, 1.6883F siRNA decreases accumulation of 
RNA from non-coding intragenic or intronic regions with elevated H3K9me2 (Figure 
3.11).  The apparent increase in 1.6883F expression (Figure 3.11) is from the transgene 
used to produce ectopic 1.6883F siRNA.  We detected dramatic reductions in messages 
adjacent to 1.6881A (tyn, G9a) and 1.6883F (ec, roX1).  In spite of a 90% reduction in ec 
transcript in embryos expressing 1.6883F siRNA, adults of this genotype do not display 
the rough eye ec phenotype.  It is possible that ectopic 1.6883F siRNA has a more 
pronounced effect in embryos, whose undifferentiated cells may be particularly 
susceptible to chromatin-based disruption.  Mature patterns of chromatin organization 
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are established by late larval life, and these may be more resistant.  To test this, we 
examined expression in wild type and 1.6883F siRNA-expressing 3rd instar male larvae, 
and found that tyn, G9a and ec regained wild type levels of transcript, and roX1 was 
also largely restored (Figure 3.11). This might be due to recovery upon establishment of 
mature chromatin. The precise reason for the differences between embryos and larvae 
are uncertain, but restoration of normal gene expression by the 3rd instar larvae is 
consistent with the lack of phenotype in otherwise wild type flies that ectopically express 
1.6883F siRNA (Menon et al., 2014).  
The discovery that animal age influenced the response to ectopic siRNA 
prompted us to determine the time point at which H3K9me2 is established at 1.688X 
repeats. A possible scenario is that this mark is placed before MSL localization, and 
acts in some way to guide X recognition.  X-localization of the MSL complex occurs at 3 
hr after egg laying (AEL) (Meller, 2003; Rastelli et al., 1995). We determined H3K9me2 
enrichment at 1.6883F in embryos before the MSL complex binds to the X (1.5-3 hr), 
during initial MSL recruitment (3-4 hr), and at 4-6 hr and 6-12 hr.  In contrast to our 
prediction, H3K9me2 is first detected on 1.6883F between 6 and 12 h AEL, after X 
localization of the MSL complex has occurred (Figure 3.12).  We conclude that 
H3K9me2 at 1.688X repeats is unlikely to guide initial X recognition, but may serve at a 
later time point to facilitate spreading of this mark or enforce the stability of X 
recognition. 
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Figure 3.8. Mating scheme to generate Su(var)3-9 mutants expressing 1.6883F 
siRNA. [hp1.6883F] [Sqh-Gal4] is marked by w+, enabling identification through the 
multiple crossing steps. Su(var)3-91 was followed by a 3rd chromosome balancer and at 
the final step non-Tb 3rd instar males were collected for ChIP.   
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Figure 3.9. Su(var)3-9 deposits H3K9me2 at some 1.688X repeats. Chromatin from 
wild type male larvae (white), Su(var)3-91/Su(var)3-91 male larvae (gray), and Su(var)3-
91/Su(var)3-91 males ectopically expressing 1.6883F siRNA (black) was 
immunoprecipitated with antibody to H3K9me2.  Enrichment normalized to input is 
shown.  Standard error is derived from two biological replicates.  See materials and 
methods and Figure 3.8 for full genotypes and larval selection strategy. 
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Figure 3.10.  Widespread alteration in H3K9me2 around 1.688X repeats is not 
reflected in global H3K9me2 level. (A) Genes over 20 kb from 1.688X repeats display 
increased H3K9me2 following ectopic 1.6883F siRNA production. (B) Western blot of 
histones from control (wild type) and 1.6883F siRNA-expressing embryos does not 
detect a change in H3K9me2 level.  H3K9me2 levels in 6-12 h embryos were compared 
to a tubulin loading control.  Sample dilution was used to confirm signal linearity.  Signal 
intensity was determined by ImageJ software.  Standard error is derived from three 
biological replicates. 
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Figure 3.11. Accumulation of transcripts from 1.688X repeats and surrounding 
regions is influenced by 1.6883F siRNA. Transcript accumulation in 6-12 h embryos 
(white and gray bars) and male larvae (hatched and black bars) was measured by 
quantitative RT-PCR. White and hatched bars are controls. Gray and black bars 
express 1.6883F siRNA. Expression is normalized to dmn.  Standard error is derived 
from two biological replicates. 
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Figure 3.12. H3K9me2 deposition on 1.6883F chromatin occurs 6-12 h AEL. 
Chromatin from staged embryos was subjected to ChIP for H3K9me2.  X-localization of 
the MSL complex is first detected at 3 h AEL (after egg laying), but H3K9me2 
enrichment is not apparent until 6-12 h AEL. Standard error is derived from two 
biological replicates. 
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H3K9me2 is enriched at regions flanking autosomal 1.6883F transgenes 
One challenge of studying recruiting elements on the X chromosome is that the 
redundancy and proximity of elements complicates interpretation.  To overcome this we 
tested integrations of 1.6883F or roX1 on 2L (Figure 3.13 A, B, 3.14 A) (Joshi and Meller, 
2017).  ChIP for H3K9me2 was performed on chromatin from male 3rd instar larvae with 
1.6883F or roX1 integrations on 2L (gray bars, 3.14 B, C), and in the same genotypes 
but with ectopic expression of 1.6883F siRNA (black bars, Figure 3.14 B, C).   H3K9me2 
is not strongly enriched in autosomal chromatin flanking roX1, but is striking enriched 
near the 1.6883F integration.  Consistent with our observations in embryos, ectopic 
1.6883F siRNA expression elevated H3K9me2 near the 1.6883F integration.  This 
contrasts with negligible enrichment at the roX1 transgene (Figure 3.6, Figure 3.14 B, 
C).  For reasons that we do not understand, enrichment over the integrated 1.6883F 
repeats was undetectable.  We conclude that autosomal insertion of 1.688X DNA makes 
nearby chromatin subject to siRNA-induced H3K9me2 deposition. Taken together, 
these studies support the idea that the 1.688X repeats influence patterns of H3K9me2 
nearby, but roX1, with a different class of recruiting element, does not.  
To determine the influence of 1.6883F and roX1 on transcription of nearby 
autosomal genes, we performed quantitative RT-PCR (qRT PCR) on total RNA from 3rd 
instar male larvae with the 2L integrations described above, with and without ectopic 
1.6883F siRNA. The 1.6883F and roX1 integration site is in an intron of haf, one of the 
genes measured.  We also examined RFeSP, CG33128, Eno (2, 58 and 114 kb from 
haf, respectively), and CG31778 and Rpl37A, 2.1 and 3.5 Mb from haf (Figure 3.14 D).  
The presence of 1.6883F or roX1 integrations alone had no effect on the most distant 
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genes, CG31778 and Rpl37A.  A roX1 integration increased expression of haf 2.5 fold, 
more than expected from full compensation.  This may reflect the fact that autosomal 
MSL recruitment by a roX1 transgene can overcome local, chromatin-based silencing 
(Kelley and Kuroda, 2003).  Addition of 1.6883F siRNA increased haf expression slightly, 
and similarly increases expression of CG33128 and Eno (light gray bars, Figure 3.14 E).  
A 1.6883F insertion produced a four-fold increase in haf, and a slight increase in 
Eno, 114 kb distant.  But upon expression of 1.6883F siRNA, haf expression increased 
to 8 fold wild type levels, and CG33128 and Eno both increased to ~2 fold wild type 
levels, consistent with full compensation.  We conclude that an autosomal insertion of 
1.688X DNA allows relatively distant genes to increase expression, an effect that is 
enhanced by 1.6883F siRNA.     
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Figure 3.13. Mating scheme to generate flies that express 1.6883F siRNA with 
1.6883F repeat and roX1 autosomal insertion. (A-B) Virgin females carrying an X 
chromosome transgene that ectopically expresses 1.6883F siRNA were mated with 
males with Binsincy X chromosome balancer and Curly, a second chromosome 
balancer. Virgins containing the X chromosome transgene, Binsincy, and Curly were 
collected. Simultaneous crosses of females carrying the same siRNA expression 
system on the X and the In (2L2R)BcG second chromosome balancer were mated to 
males with a 1.6883F (A) or roX1 (B) transgene at cytological location 22A3. Male 
offspring from this cross with a balanced second chromosome 1.6883F or roX1 
transgene were mated to sisters with balanced second chromosome transgenes. 
Offspring with the appropriate genotypes were collected and maintained as a stock.  
 
A 
B 
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Figure 3.14. Ectopic 1.6883F siRNA increases H3K9me2 flanking an autosomal 
1.6883F DNA insertion and elevates expression of nearby genes. (A) Amplicons 
flanking the landing site in a large haf intron at 22A3 (splicing not shown). (B) H3K9me2 
enrichment surrounding the 1.6883F transgene.  Chromatin from wild type third instar 
male larvae (white), larvae with 1.6883F DNA at the landing site (gray), and larvae with 
1.6883F DNA at the landing site and ectopic 1.6883F siRNA (black) was 
immunoprecipitated with antibody to H3K9me2. (C) H3K9me2 enrichment surrounding a 
roX1 insertion.  Chromatin from wild type male third instar larvae (white), larvae with the 
roX1 insertion (gray), and with the roX1 insertion and ectopic 1.6883F siRNA (black) was 
immunoprecipitated.  Data is from two biological replicates and enrichment is 
normalized to input.  (D) Portion of 2L showing relative location of CG33128, haf, 
RFeSP, Eno, CG31778, and Rpl37A.  (E) Accumulation of transcripts in male larvae 
carrying roX1 (white) or 1.6883F insertions (dark gray), and in male larvae that express 
ectopic 1.6883F siRNA and have roX1 (light gray) or 1.6883F integrations (black). 
Expression is normalized to dmn.  SEM is derived from three biological replicates. 
Significance was determined using Student’s two sample t-test, ≤0.05 (*), ≤0.001 (**) 
significance. Primers are presented in Appendix H. 
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Discussion 
Molecularly distinct dosage compensation strategies have arisen independently 
in different organisms, but a shared feature is the ability to selectively recognize and 
alter an entire chromosome.  How a regulatory system is directed to a single 
chromosome is poorly understood.  The discovery that 1.688X satellite DNA promotes 
recruitment of dosage compensation to nearby genes supports the idea that these 
repeats are important for selective recognition of X chromatin (Joshi and Meller, 2017).  
How the 1.688X repeats accomplish this is a question of great interest.  Involvement of 
the siRNA pathway, and siRNA from a 1.688X repeat, in X recognition points to the 
possibility that siRNA-directed modification of chromatin around 1.688X repeats plays a 
role in dosage compensation.  The findings of the current study support this idea. 
 Although numerous studies point to small RNA regulation of chromatin in flies, 
this process is better understood in other organisms (reviewed in (Meller et al., 2015)).  
Small RNA directed heterochromatin formation was discovered in S. pombe (reviewed 
in (Moazed, 2009)). Heterochromatic regions are transcribed during S phase, and 
transcripts are processed into siRNAs that guide the Ago1-containing RITS complex to 
complementary, nascent transcripts (Verdel et al., 2004).  In addition to several other 
activities, RITS recruits the H3K9 methyltransferase Clr4 (Zhang et al., 2008).   We 
propose that a similar process is occurring at 1.688X chromatin in flies.  Most 1.688X 
repeats bind Ago2, and many are transcribed.  Several of the 1.688X repeats that we 
examined are enriched for H3K9me2 deposited by Su(var)3-9, an ortholog of Clr4.  Our 
screen identified genetic interactions between roX1 roX2 and members of a possible 
RITS-like complex consisting of Ago2, Rm62 and Su(var)3-9.  Finally, H3K9me2 
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enrichment in, and around, 1.688X repeats is responsive to 1.688X siRNA, and 
enrichment is blocked by loss of Su(var)3-9.  Taken together, these findings are 
suggestive of a RITS-like complex modifying chromatin at 1.688X repeats. 
The idea that repressive H3K9me2 marks participate in a process culminating in 
a two-fold increase in expression is counterintuitive.  However, numerous studies have 
found links between the compensated X chromosome of male flies and repressive 
marks.  For example, the male X is enriched in HP1, a major constituent of 
heterochromatin that binds H3K9me2 (de Wit et al., 2005; Liu et al., 2005).  The 
structure of the polytenized male X chromosome is extraordinarily sensitive to altered 
levels of genes that participate in heterochromatin formation or silencing, such as HP1, 
Su(var)3-7 and ISWI.  Mutations in these genes produce a general disruption of 
polytenization that is strikingly specific to the male X (Deuring et al., 2000; Spierer et al., 
2005; Zhang et al., 2006).  JIL-1, a kinase that enforces boundaries between 
heterochromatin and euchromatin, is enriched on the X chromosome and thought to 
participate in compensation (Deng et al., 2005a; Ebert et al., 2004; Jin et al., 2000; 
Wang et al., 2001).  Upon loss of JIL-1, polytenized structure is disrupted and H3K9me2 
invades euchromatic chromosome arms, but the X chromosome is most severely 
affected (Zhang et al., 2006).  Finally, the MSL proteins themselves have an affinity for 
heterochromatin.  In roX1 roX2 mutant males the MSL proteins become mislocalized to 
ectopic autosomal sites (Meller and Rattner, 2002).  For reasons that are still unclear, 
the most prominent of these sites are the heterochromatic 4th chromosome and 
chromocenter (Deng and Meller, 2006; Figueiredo et al., 2014).  Taken together, these 
observations suggest that recognition and spreading of the MSL complex could be 
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facilitated by repressive marks.  One intriguing possibility is that 1.688X repeats guide 
deposition of H3K9me2 and this mark, directly or indirectly, assists localization of the 
MSL complex.  
An intriguing aspect of dosage compensation is the evolutionary convergence of 
mechanisms.  For example, long non-coding RNA also plays a central role in X 
recognition in mammals, where expression of the X inactive specific transcript (Xist) 
RNA guides X inactivation (Lee, 2009).  Furthermore, repetitive LINE-1 elements that 
are enriched on the mammalian X chromosome are proposed to facilitate X inactivation 
(Bailey et al., 2000; Lyon, 1998).  Interestingly, some LINE-1 elements are transcribed 
during the onset of X inactivation, producing endo-siRNAs that may guide local 
spreading of heterochromatin into regions that are otherwise prone to escape (Chow et 
al., 2010).  These parallels are particularly striking as the outcomes, silencing of an X 
chromosome in mammalian females and activation of the single X in male flies, appear 
unrelated.   We propose that cooperation between distinct chromatin-modifying systems 
that rely on long and short non-coding RNAs is one strategy to selectively modulate an 
entire chromosome. 
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CHAPTER 4 SUMMARY AND PERSPECTIVES 
Accurate gene regulation is a fundamental requirement for health and proper 
development. We have a sophisticated understanding of how individual genes are 
controlled, but the mechanisms that coordinately control large regions of the genome 
remain poorly understood.  Studies of sex chromosome dosage compensation in model 
organisms are a valuable contribution to a comprehensive understanding of gene 
regulation.  My research investigated a mechanism that contributes to whole 
chromosome recognition in flies.  Significantly, this mechanism is evolutionarily 
conserved, suggesting a potential role in domain-wide regulation in other species. 
A family of 1.688X repeats is strikingly enriched on the fly X chromosome, 
suggesting that these might participate in X recognition. Some of these repeats have 
been shown to produce siRNA, and siRNA from one of these repeats acts to facilitate X 
recognition (Menon et al., 2014).  Autosomal insertions of DNA from these repeats 
recruits the MSL complex to nearby genes (Joshi and Meller, 2017).  The involvement 
of siRNA and DNA from these repeats in X recognition spurred me to ask if chromatin at 
the repeats is modified in an siRNA-dependent manner. I discovered that the 1.688X 
repeats are enriched for Ago2, Ago2 interacts genetically with roX1 roX2 mutants.  
Many 1.688X repeats are also enriched for H3K9me2, deposited by the Ago2-interacting 
protein Su(var)3-9, itself displaying genetic interactions with roX1 roX2 mutants.  The 
H3K9me2 mark is responsive to cognate siRNA.  Taken together, these observations 
reveal that the siRNA pathway does modulate chromatin at 1.688X repeats on the X.  As 
redundancy of repeats on the X chromosome makes it difficult to study the effect of a 
single repeat, we used autosomal insertions of 1.688X DNA to observe chromatin 
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modifications and alterations in gene expression nearby. Autosomal insertion of 1.688X 
DNA increases H3K9me2 in flanking regions and elevates expression of nearby genes.  
Both are further elevated by ectopic 1.688X siRNA. These findings confirm the effect of 
1.688X repeats on flanking chromatin and expression of nearby genes.  But many 
unanswered questions remain. The association of the repressive H3K9me2 mark with 
dosage compensated chromatin remains paradoxical.  The mechanism by which 1.688X 
chromatin attracts dosage compensation remains a mystery. Further investigations 
addressing the following questions will lead to a better understanding of mechanisms by 
which these repetitive elements regulate X identification in Drosophila.  
Does an Ago2-containing effector complex localize at 1.688X repeats? 
We have shown that FLAG-Ago2 localizes at many 1.688X repeats. In fission 
yeast, an Argonaute-containing RNA-induced transcriptional silencing (RITS) complex 
recruits a histone methyltransferase to repetitive chromatin. The RITS complex 
identifies these sites by base pairing between siRNA and nascent transcripts (Verdel et 
al., 2004). We predict that a RITS-like Drosophila complex is recruited to the 1.688X 
repeats by a similar mechanism. We also demonstrated that Su(var)3-9 places the 
H3K9me2 mark at 1.688X repeats, but demonstrating that Su(var)3-9 protein localizes at 
the 1.688X repeats by ChIP with anti-Su(var)3-9 would solidify this observation.  My 
genetic screen revealed a sub-network consisting of Ago2, Rm62, Su(var)3-9, Dcr1, 
and Fmr1 that interacts genetically with roX1 roX2.  It is possible that these proteins 
form a RITS-like complex.  In support of this hypothesis I found that the Rm62 helicase 
is increased at 1.688X repeats in embryos that ectopically express 1.6883F siRNA 
(Appendix G).  ChIP studies and co-immunoprecipitation could be performed on the 
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other proteins in this sub-network to examine localization at 1.688X repeats and 
association with each other. 
What is the relationship between H3K9me2 and MSL complex localization? 
It is counterintuitive that the repressive H3K9me2 contributes to dosage 
compensation, a process that leads to hypertranscription of the male X chromosome. 
However, many studies have found links between repressive marks and male X 
chromosome.  The X chromosome is enriched for HP1, a protein that binds H3K9me2 
(de Wit et al., 2005; Liu et al., 2005).  Jil-1, a kinase enriched on the X chromosome,  
maintains euchromatin and heterochromatin boundaries is also linked to dosage 
compensation (Deng et al., 2005a; Ebert et al., 2004; Jin et al., 2000). Upon JIL-1 
mutation, euchromatin-heterochromatin boundaries are disrupted and the X becomes 
particularly enriched for H3K9me2 (Deng et al., 2005a). Mutations in Su(var)3-7, a 
heterochromatin factor, disrupt the polytenized male X chromosome and reduce survival 
of roX1 roX2 males (Figure 3.4, (Spierer et al., 2005)). The repressive chromatin 
remodeler ISWI is another protein whose mutations preferentially affect the polytenized 
male X (Corona et al., 2007). Although the link between repressive chromatin marks 
and dosage compensation is still unclear, our ability to recapitulate compensation on an 
autosome may allow a systematic dissection of this process.  
Do the 1.688X repeats affect interphase conformation of the X chromosome?  
Interphase architecture of the X chromosome has been shown to have a male-
specific conformation, although the details of this conformation, and how it is 
established, remain in dispute (Grimaud and Becker, 2009; Mendjan et al., 2006; 
Ramirez et al., 2015).  The general consensus is that a male-specific X conformation 
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helps to distribute the MSL complex along the entire X chromosome.  It is possible that 
the 1.688X repeats contribute to a chromosome-specific conformation.  The clade of 
1.688X repeats that I have studied is near-exclusive to the X, and the AT-rich sequence 
has high similarity to Matrix Attachment or Scaffold Attachment Regions (MAR/SAR).  
MAR/SAR anchors are required for the formation of chromatin loops (Heng et al., 2004).  
The role of 1.688X repeats in affecting X conformation could be tested by Chromosome 
Conformation Capture (3C), a technique that reveals long-range interactions. 
Additionally, these repeats could be tested for association with the nuclear matrix.  The 
1.688X repeats also have very strong similarity to a sequence favored by topoisomerase 
2 (Top2), a known component of the nuclear matrix (Adachi et al., 1989; Berrios et al., 
1985; Meller et al., 1995). Interestingly, mutations in barren (barr) a Top2 activator, 
enhance the male lethality of roX1 roX2 mutants (Figure 3.4). Additionally, the proteins 
D1 and HP1 interact with nuclear lamins and Top2 (Blattes et al., 2006).  Interestingly, 
D1 localizes to a group of closely related satellite repeats that makes up most of the 
pericentric heterochromatin of the X chromosome (Aulner et al., 2002; Blattes et al., 
2006).  One exciting direction for future studies is an exploration of the relationship 
between X conformation, the nuclear lamin and 1.688X repeats on the X chromosome. 
Does ectopic expression of 1.688X siRNA result in global alterations in H3K9me2? 
In Chapter 3 I discovered a widespread increase of H3K9me2 along the X 
chromosome upon expression of 1.6883F siRNA, but no apparent alteration of global 
levels of H3K9me2 (Figure 3.10). H3K9me2 is also modestly increased at autosomal 
sites, sparking concern that 1.688X siRNA drives a genome-wide redistribution of 
H3K9me2 (Figure 3.6).  For example, 10 Mb of pericentric heterochromatin on the X 
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chromosome is composed of a closely related satellite sequence.  It is possible that 
ectopic 1.688X siRNA disrupts H3K9me2 enrichment in this region, much as it does at 
the euchromatic 1.688X repeats.  To address this we propose to use ChIP-Seq to 
compare the distribution of H3K9me2 in embryos from the laboratory reference strain, 
and embryos ectopically expressing 1.688X siRNA. This will enable us to compare 
enrichment of H3K9me2 in heterochromatin and euchromatin genome-wide, and 
compare the X chromosome to the autosomes.  siRNA-induced changes will be 
visualized using read pileups of H3K9me2 peaks in sliding window format across the 
genome.  This will reveal whether a global redistribution of this mark occurs upon 
1.688X siRNA production. Heterochromatin-euchromatin boundaries will be defined by 
the patterns observed in the wild type embryos.  Studies in a number of cell types and 
developmental stages reveal a remarkably distinct boundary between the euchromatic 
chromosome arms and pericentric heterochromatin (Riddle et al., 2011).  The studies 
presented in Chapter 3, performed on a panel of six representative 1.688X repeats, 
indicate that ectopic 1.688X siRNA production leads to redistribution of H3K9me2 within 
1.688X repeats and increases H3K9me2 in surrounding regions.  ChIP-seq data could 
be used to generate “gene models” of repeats and flanking regions to test the generality 
of this observation.  Repeat clusters could also be sorted by the level of transcription to 
test the idea, put forth in Chapter 3, that H3K9me2 enrichment over 1.688X repeats 
correlates with the level of transcription across the repeat. Although a correlation, by 
itself, is not proof of mechanism, a positive relationship would be suggestive of a 
cotranscriptional mechanism driving H3K9me2 enrichment.   
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APPENDIX A OPTIMIZATION OF MNASE ASSAY TO DETECT CHANGES IN 
CHROMATIN ACCESSIBILTY 
 
Dosage compensation involves male-limited modification of the X-chromosome. I 
hypothesize that Ago2 and siRNA recruits a RITS-like complex that modifies chromatin 
at 1.688X repeats to influence chromatin accessibility. It is possible that siRNA-
dependent modification of 1.688X chromatin differs in the sexes.  To address this 
question I attempted to develop an MNase assay to determine chromatin accessibility at 
1.688X repeats.  When implemented, this assay could also be used to explore chromatin 
structure at the repeats in RNAi mutants, and to determine if ectopic expression of 
siRNA from the 1.6883F repeats influences chromatin accessibility.  
Microccocal nuclease (MNase) cleaves DNA at sites that are not occupied by 
nucleosomes or DNA binding proteins.  Isolation of nuclei from intact animals is tricky 
as larvae and adults have a digestive tract full of nucleases.  Isolation of embryonic 
nuclei is standard, but it is impractical to sex or genotype embryos. In contrast, salivary 
glands can be isolated from 3rd instar larvae that have been sexed and genotyped. I 
decided to isolate nuclei from the salivary glands of 3rd instar larvae, incubate them 
with different concentrations of MNase, extract DNA and perform a quantitative PCR 
(qPCR) with primers specific for the 1.688X repeats and control regions.  Accessible 
DNA will be cleaved at lower MNase concentrations, reducing the relative amount of 
template from these regions. 
A hypothetical plot of template remaining after digestion with different MNase 
concentrations is shown in Figure A1.  The y-intercept indicates the initial amount of 
DNA or template.  A steeper initial slope indicates greater accessibility (red line, Figure 
A1 A). Accessibility could be inferred from the 50% destruction point where a shift to 
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the right would indicate less accessibility and a shift to the left would indicate more 
accessible chromatin.  Data could also be represented on a logarithmic scale in which 
template remaining is indicated by RT PCR cycle number (Ct, Y axis) (Figure A1 B).  
The log of MNase concentration is plotted on the X-axis.  This graph is expected to 
produce a straight line, facilitating determination of slope. 
The completion of this study was intended to reveal if animal sex, Ago2 or 
1.688X siRNA plays a role in establishing chromatin organization at the 1.688X repeats.  
If Ago2 modifies chromatin at the 1.688X repeats then a difference in the slopes of 
lines following digestion of control and Ago2 mutant nuclei is anticipated (Figure A2). I 
may see a difference in their slopes if the male 1.688X repeat differs in accessibility 
than the female 1.688X repeat.  A difference of Ct cycle in undigested samples should 
be observed, as the females have two copies of 1.688X repeats and the males have 
one copy.  
  
65 
 
 
 
          A.                                                                           B. 
  
Figure A1. Comparison of conventional and logarithmic representations of MNase 
assay. (A) A conventional plot that shows decrease in template with the increase in 
MNase concentration. (B) Logarithmic plot depicting MNase concentration on the X-axis 
and Ct value on the Y-axis. A more accessible template is depicted by the higher slope 
of the red line, and the blue line depicts lower initial template concentration. 
 
 
 
 
Figure A2. log-log representation of MNase assay for wild type and Ago2 mutants. 
The left graph depicting differences in the slopes indicate that Ago2 is necessary for 
manipulating chromatin structure. The right graph with parallel lines indicates that Ago2 
has no role in manipulating chromatin structure. 
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Nuclei Isolation 
A nuclei isolation protocol was adapted from (Boyd et al., 1968; Weinmann et al., 
1999). The protocol was carried out at 4˚C in tubes pretreated with Nuclear Purification 
Buffer (NPB, 20 mM MOPS pH 7, 10 mM NaCl, 0.5 mM spermidine, 0.2 mM spermine, 
3 mM MgCl2) with 1 % BSA (Deal and Henikoff, 2010). Sixty pairs of salivary glands 
were dissected in Ringer's solution, washed and resuspended in 200 µl NPB. Eight µl 5 
% Triton X-100 was added and the glands were disrupted by gentle pipetting. The 
suspension was passed through a nylon mesh to remove cell debris, made up to 1 ml 
and spun at 500 rpm for 5 min at 4˚C to concentrate nuclei. The supernatant was 
discarded, leaving behind about 50 µl NPB.  The nuclei were washed with 50 µl of 
MNase Digestion buffer without CaCl2 (10 mM Tris-Cl pH 7.5, 15 mM NaCl, 60 mM KCl) 
and collected at 6000 rpm for 10 min at 4˚C. A translucent pellet was visible after 
discarding the supernatant. The pellet was resuspended in 90 µl of MNase Digestion 
buffer with 1 mM CaCl2.  
Nuclei might settle or clump, producing inaccuracy.  To evaluate this, 6 aliquots 
were mock digested, stained with DAPI and nuclei counted.  The number of nuclei per 
10 µl aliquot ranged from 72-99. 
MNase Digestion 
MNase digestion was performed as described in (Weinmann et al., 1999) with 
minor modifications. Five µl of MNase (NEB, Catalog #M0247S) in MNase Disgestion 
buffer with 1 mM CaCl2 was added to 45 µl of isolated nuclei and and mixed gently. 
Digestion proceeded at RT for 5 min, followed by 30 min at 37˚C. The reaction was 
terminated by addition of 10 mM EDTA, 1 % SDS, 400 μg/ml proteinase K and tubes 
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were incubated at 55˚C for 2 hrs. Samples were phenol-chloroform extracted, DNA was 
recovered by precipitation and resuspended in 20 μl distilled water.  Two μl DNA was 
used to template RT PCR reactions that included 10μl of SyBr Green (BioRad iTaq, 
#172-5101), 4 μl primers and 4 μl distilled water. Amplicons were designed to span 
nucleosomes. The primers are presented in Table A1. 
The concentration of nuclease required and the duration of digestion was first 
determined.  MNase concentrations between 0 and 31.25 units/ml, and digestion times 
of 30 and 60 min were initially tested (Figure A3).  The 30 min incubation produced 
acceptable results (Figure A3).  A linear decrease in template was observed up to 31.25 
units/ml.  I decided to use MNase dilutions of 10, 30, and 100 units/ml for the MNase 
assay (Figure A4).  The autosomal gene CTCF served as a non-repetitive control that is 
not an expected target of siRNA-dependent chromatin modification. Amplification of 
CTCF, 1.6883F, and 1.6883C repeats produced a linear response to MNase 
concentration from which the slope could be calculated (Figure A5).  A plasmid control 
consisting of serial dilutions of a plasmid containing cloned 1.6883F repeat DNA was 
amplified at two dilutions (105, 107) chosen such that their Ct values were 22 and 28.  
This was developed to enable comparison between different experiments. 
Although optimization of the MNase assay appeared promising, it proved 
impossible to replicate results in a predictable manner.  As an alternative method of 
evaluating the status of chromatin at 1.688X repeats, we switched to chromatin 
immunoprecipitation to determine the epigenetic marks over these regions, and explore 
how these marks respond to 1.6883F siRNA. These studies are detailed in Chapter 3.     
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Figure A3. Optimization of MNase Digestion time. Wild type nuclei were treated 
with varying MNase concentrations and digestion carried out at 37˚C for 30 mins (blue) 
and 60 mins (red).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4. Determining MNase concentration range. A log-log plot of amplification of 
the 1.6883F repeats.  Log MNase concentration is on the X-axis, and Ct value on the Y-
axis. 
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Figure A5. MNase assay in wild type flies.  A log-log plot of amplification of an 
autosomal control – CTCF (black line), 1.6883F (dashed black line), and 1.6883C repeats 
(dotted black line).  
 
 
Target Primer Sequence 
Conc. 
(nM) 
Efficiency 
CTCF 
CTCF MNase F1 GCGAGAAATCGATAAGCGC 
300  107.2 
CTCF MNase R1 GTACTGACCACGGAACGTGT 
1.6883F 
3F MNase F1 AGCATCCACAAGAATGGGAAG 
300  99.4 
3F MNase R1 TGCCAATAAACATAGCTAACTATCC 
1.6883C 
3C MNase F2 CGATGTTATGGCGAAAATACCGT 
300  97.2 
3C MNase R2 AGAACTTAGAACGACTTTACGCA 
 
Table A1. List of primers used for quantitative RT-PCR studies. CTCF is used an 
autosomal control and primers on the 1.6883F and 1.6883C repeats are used as test.  
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APPENDIX B INVESTIGATING THE ROLE OF SU(VAR)3-9 IN X RECOGNITION 
  The studies described here were performed with undergraduate students Taania 
Girgla and Kassem Makki.  This was a part of their summer research and Honors’ 
Thesis, respectively.  
Determining Gal4 driver strength 
The rank strength of four Gal4 drivers was evaluated to enable variable knock 
down of Su(var)3-9.  A stronger knockdown should more severely impact H3K9me2 
enrichment, the mark deposited by the Su(var)3-9 protein. This could be used as a tool 
to investigate the role of Su(var)3-9 in X recognition.  The genotype, stock number, and 
the location of different Gal4 drivers is presented in Table B1.  All stocks, excepting w*; 
P{matα4-GAL-VP16}V2H, had an intervening sequence between the Act5 promoter and 
Gal4 that prevents Gal4 production.  Intervening sequences, flanked by tandem Frt sites 
(Flip Recombinase Target), are removed by flippase (Flp), supplied by an X-linked 
transgene. The Flippase stock description is shown in Table B1.  Excision of the 
intervening sequence was determined by disappearance of the y+ marker. Gal4 strains 
with excised intervening sequences were mated to flies containing UAS-GFP to visually 
score driver strength (Table B1), and to assess the success of excision.  Flippase 
efficiently removed intervening sequences. Once qualitatively scored, stocks of the four 
driver lines were used for Su(var)3-9 knockdown. 
 
 
71 
 
 
 
Table B1. Qualitative ranking of Gal4 drivers using a GFP reporter.  Gal4 drivers 
were compared and ranked.  The rank order of weakest (+) to strongest (++++) drivers 
is derived from relative GFP expression. 
 
 
 
 
Genotype 
BDSC 
Stock 
Chromosome 
Excised 
Portion 
Renamed 
Stocks  
Driver 
Strength 
w118;P{AyGAL4}17b 4413 3 y 
4413 
∆GAL4 
++ 
y1 w* P{GAL4-
Act5C(FRT.CD2).P}
D 
4779 X CD2 
4779 
∆GAL4 
+++ 
y1 w*; P{GAL4-
Act5C(FRT.CD2).P}
S 
4780 3 CD2 
4780 
∆GAL4 
++++ 
w*; P{matα4-GAL-
VP16} 
V2H 
7062 2 - - + 
P{w[+mC]=ovo-
FLP.R}M1A, w[*] 
8727 X - - - 
yw 
-ve 
Control 
- - - - 
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Knock down of Su(var)3-9  
Based on the strength of the Gal4 drivers, we decided to test the weakest (w*; 
P{matα4-GAL-VP16}V2H) and strongest (yw; {4780ΔGal4}) drivers to create Su(var)3-9 
knockdown flies.  Fifty virgins with each driver were mated to male UAS-Su(var)3-9 
(w1118; UAS-Su(var)3-9 VDRC 101494/KK,) and TRiP-Su(var)3-9 (y1 sc* v1; 
P{TRiP.HMS00279}attP2, BDSC 33401), or to a laboratory reference strain lacking a 
knock down construct. No embryos obtained from matings with the strong {4780ΔGal4} 
driver developed into larvae.  Zero-12 h and 12-24 h embryos were collected from 
matings using the weakest driver, P{matα4-GAL-VP16}V2H)  These embryos were 
washed with wash solution (7 g NaCl, 3 ml Triton X-100, 997 ml water) and 
dechorionated using 50% bleach for 3 min. The dechorionated embryos were fixed 
using a 1:1 ratio of 4% paraformaldehyde and n-heptane for 25 min. The lower phase 
was removed, replaced with equal amount of methanol and shaken for 15 s. This step 
removes the vitelline membrane, allowing embryos to sink to the bottom. The 
supernatant and any embryos that did not sink were removed, and remaining embryos 
washed twice with methanol.  Embryos were washed three times with PBT (PBS + 0.1% 
Tween 20) for 5 min each, stained with DAPI for 5 min and washed once with PBT for 
15 min. PBT was removed and 10% glycerol added as the mounting medium.  Embryos 
in different developmental stages were counted for the three matings and the percent of 
total embryos for each meeting determined (shown in Figure B1).  The developmental 
profiles for the three matings did not reveal any striking differences. As similar number 
of females and males were used for mating, and the embryos were collected at the 
same time, the total number embryos obtained from each matings were also compared.  
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The matings with UAS-Su(var)3-9 and TRiP-Su(var)3-9 reduced the total number of 
embryos to 33% and 42% of that obtained for the control mating. This decrease in 
number of embryos could reflect strain-specific differences in female fecundity unrelated 
to knock down. Although decrease in number of embryos is observed in the matings 
with UAS-Su(var)3-9 and TRiP-Su(var)3-9 with the weakest driver, all the embryos 
eclosed to adult flies.   
Next, I performed qRT-PCR to quantify Su(var)3-9 transcript.  Su(var)3-9 has 5 
exons, the first two unique to Su(var)3-9 and the last 3 shared with eIF2γ.  I designed 
primers spanning the 1st and the 2nd exon (Table B2). Relative transcript in 3rd instar 
larvae from matings between w*; P{matα4-GAL-VP16}V2H and UAS-Su(var)3-9, and 
w*; P{matα4-GAL-VP16}V2H and TRiP-Su(var)3-9 showed decrease in Su(var)3-9 
transcripts (Figure B2). 
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Figure B1. Embryo count from different developmental stages of Su(var)3-9 
knockdown embryos. Percent total embryos obtained from matings between 
laboratory reference strain (yw) and the weakest driver (w*; P{matα4-GAL-
VP16}V2H) are shown in white. Gray bars show percent total embryos from matings 
between UAS-Su(var)3-9 and the weakest driver, and black bars show percent total 
embryos from matings between TRiP-Su(var)3-9 and the weakest driver.  
 
 
 
Figure B2. Accumulation of Su(var)3-9 transcripts is decreased in flies that are 
knockdown for Su(var)3-9. Transcript accumulation in 3rd instar larvae was 
measured by quantitative RT-PCR.  
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Generating Su(var)3-9 knockdown flies. 
Although we were successful in achieving Su(var)3-9 knockdowns, fly stocks 
used to achieve Su(var)3-9 knockdown also target an essential overlapping gene, 
eIF2γ.  Because of this, knockdown with a strong driver caused lethality.  To limit knock 
down to Su(var)3-9, I worked with Kassem Makki, an undergraduate honors student. 
His study focused on generating an RNAi knockdown construct that targets an exon 
exclusive to Su(var)3-9. This would allow elimination of Su(var)3-9, without disrupting 
eIF2γ.  
To accomplish this, an exon present only in Su(var)3-9 was cloned into a pWIZ 
vector.  pWIZ is designed to facilitate generation of transgenic flies for RNAi knockdown 
(Bao and Cagan, 2006).   The pWIZ vector allows generation of dsRNA in flies, which is 
processed into siRNA. This vector will be injected in fly embryos to create strains that 
knockdown Su(var)3-9 when combined with a Gal4 driver.  
We amplified a 450 bp segment from the 2nd exon of Su(var)3-9 with primers that 
would create AvrII restriction enzyme sites.  The PCR product was purified and cloned 
in a pCR4 Topo cloning vector, enabling us to sequence and amplify the insert before  
cloning into pWIZ. The pWIZ vector was digested with AvrII and ligated to an AvrII-
digested insert.  Colony PCR was performed using a reverse primer in the insert and a 
forward primer in the hsp70 promoter present in pWIZ) (Table B2, Figure B4).  A clone 
with insert was identified and used for the second cloning step at Nhe1. 
Cloning in NheI site proved to be challenging.  After many failed attempts we 
decided to use an alternative approach to show role of Su(var)3-9 in depositing 
H3K9me2 at the repeats (Chapter 3, Figure 3.9).  
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Primer name Sequence 
Working  
Conc. (nM) 
Efficiency 
Su(var)3-9 
F2 
CCACGGTGGTCAAAGCCATA 300 
92.5 
Su(var)3-9 
R2 
CTGCTGCTTGGAGGTCAAAAG 500 
Hsp 70 
promoter F 
GAGAGAATTCCCCCTAGAATCCCAAAA
C 
  
Su(var)3-9 
ex AvrII FP1 
ATTCCATGGGTAGATAGACGCACCACC
CG 
  
Su(var)3-9 
ex AvrII RP1 
TAACCATGGATGCGCTTCTCGAACAAT
GC 
  
 
Table B2. Primer table. Primer Su(var)3-9 F2, R2 were used for qRT-PCR. Hsp70 
promoter, Su(var)3-9 ex AvrII primer pairs were used for cloning in pWIZ.  
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APPENDIX C DETERMINATION OF GENOME WIDE ALTERATIONS IN H3K9ME2 
LEVEL IN FLIES EXPRESSING 1.6883F siRNA 
 
The major limiting step towards carrying out ChIP-Seq is that the protocol we 
were using did not yield enough double stranded DNA to make ChIP-seq libraries.  Ten 
ng of dsDNA is required for library generation. To get ChIP-seq compliant DNA, I 
standardized the steps of chromatin generation, resulting in the protocol detailed below.  
PROTOCOL FOR CHROMATIN PREPARATION 
Overnight embryos (0.35 g) were collected, dechrorionated with 50 % bleach for 
3 min, and crosslinked for 20 min in 50 mM HEPES, 1 mM EDTA, 0.5 mM EGTA, 100 
mM NACl, 1 % formaldehyde with heptane and vigorous shaking. Crosslinking was 
stopped by adding 125 mM glycine, 0.01 % Triton X-100 in 1 X PBS for 30 min.  
Crosslinked embryos were washed once in PBS and collected at 2500 rpm for 5 min at 
4˚C. Supernatant was discarded and embryos were resuspended in 15 ml Buffer B 
(Table C1) and 1 CompleteTM protease inhibitor tablet (Roche, #11697498001), followed 
by incubation on ice for 15 min. Embryos were homogenized in a precooled Dounce, 10 
strokes with pestle A followed by 15 strokes with pestle B.  The homogenized mixture 
was centrifuged at 170 g for 10 min at 4˚C and supernatant discarded.  The pellet was 
washed twice with MNase Digest Buffer (Table C1), resuspended in 200 µl of MNase 
Digest Buffer and transferred to a 2 ml tube.  DNA was digested with 40 Units of MNase 
(2.67 µl of 15 units/ µl, Wortington Stock #LS004797) 37˚C for 30 min. Digestion was 
stopped by adding 12 µl of 0.5 M EDTA, and the volume made up to 1 ml using Ten140 
buffer (Table C1).  The sample was sonicated by a Fischer Scientific Model FB505 on 
ice at 35% amplitude, total time of 2.5 min, 30 sec on, 59 sec off, producing shearing to 
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200-600 bp (Figure C1). Sonicated chromatin was centrifuged at 12,000 rpm for 15 min 
at 4˚C and 200 µl aliquots stored at -80˚C.  
Chromatin Immunoprecipitation 
Two hundred µl of chromatin is used for each chromatin immunoprecipitation, 
which was carried out as detailed in Chapter 3 with the exception of reverse 
crosslinking. To reverse crosslinks of eluted samples, 4 µl RNase A (10 µg/µl, invitrogen 
PureLinkTM Stock #12091-021) was added and samples were incubated at 37˚C for 15 
min.  Twenty µl of 5 M NaCl was added and samples were incubated at 65˚C for 6 hr. 
Two µl of proteinase K (10 µg/µl, Thermo Scientific Stock #26160), 10 µl 0.5 M EDTA, 
and 10 µl 1 M Tris (pH 7.6) were added and samples incubated at 45˚C for 1 hr. 
Extraction with an equal volume of phenol:chloroform:isoamylalcohol (25:24:1 v/v) was 
performed, and the aqueous phase transferred to another 0.5 ml tube.  Ten µl glycogen, 
1/10 volume of 3 M sodium acetate (pH 5.2) and 2.5 volume of chilled 100% ethanol 
were added.  DNA was precipitated at -20˚C for at least one hour and pelleted at 14,000 
rpm for 15 min at 4˚C.  The pellet was resuspended in 50 µl distilled water and stored at 
-20˚C.  
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Figure C1. Reverse crosslinked chromatin. Chromatin was prepared from 6-12 hr 
embryos obtained from wild type embryos (left) and embryos expressing 1.6883F siRNA 
(right) using the revised protocol. Shearing between 200-600bp was obtained.  
 
  
600 bp 
200 bp  
Wild type 1.6883F siRNA 
100bp 
ladder 
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Re-suspension Buffer B 
Components Stock 50 ml 
10mM Tris (pH 8) 1M 500 µl 
10mM KCl 1M 500 µl 
3mM CaCl2 100mM 1.5ml  
0.34M Sucrose 1 M 5.81g 
1mM DTT 1M 50 µl 
0.1% Triton X100  50 µl 
0.2mM EGTA  0.5M 20 µl 
ddH2O   Add to 50 ml 
 
MNase Digest Buffer  
Components Stock 50 ml 
 15mM Tris (pH 8) 1M 750 µl 
60mM KCl 1M 3ml 
15mM NaCl 5M 150 µl 
1mM DTT 1M 50 µl 
0.25M Sucrose  4.27gm 
1mM CaCl2 100mM 500 µl 
ddH2O  Add to 50 ml 
 
Ten140 buffer 
Components Stock 50ml 
140mM NaCl 5 M 1.4 ml 
10mM Tris (pH 7.6) 1 M 500 µl 
2mM EDTA 0.5 M 200 µl 
ddH2O  Add to 50 ml 
 
Table C1. Buffers used for chromatin preparation.   
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APPENDIX D DETERMINING REPEAT LENGTH AND COPY NUMBER IN THE 
LABORATORY REFERENCE STRAIN 
A clade of 1.688X repeats is dramatically enriched on the X chromosome and 
involved in X recognition.  These are present in short clusters of ~359 bp tandem 
repeats that are distributed throughout euchromatin.  While the position of repeat 
clusters is stable, there is variation in the number of repeats within each cluster, and this 
can be detected by comparing different strains of D. melanogaster.  To support the 
studies described in Chapter 3, I wished to determine the number of repeats in our 
laboratory reference (yw) strain at several cytological positions.  This was done by PCR 
of DNA using primers flanking each repeats (Table D1).  The length of the amplicon 
attributable to repeats was divided it by 359 to obtain the copy number.  Prior studies 
have shown that the copy number of 1.6883F repeats in the laboratory reference strain is 
3.5. The lengths of 1.6884A, 1.6883C, 1.6887E, and 1.6887F repeats are 850 bp, 1200 bp, 
900 bp, and 500 bp, respectively, bringing their copy numbers to 2.5, 3.5, 2.5, and 1.5 
(Figure D1). As the 1.6881A repeats have a copy number of ~100, it was not possible to 
use this method to determine 1.6881A repeat length or copy number in the laboratory 
reference strain.  
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Figure D1. Determination of tandem repeat size in laboratory reference strain.  
Amplicons produced from laboratory reference strain are used to determine the number 
of tandem repeats in 1.6884A, 1.6883C, 1.6887E, and 1.6887F in the laboratory yw 
reference strain.  
 
 
Primer Name Sequence 
Amplicon 
Size 
Approx. repeat 
copy number 
4A Across F1 AGTGCGAGGTACACCGAAAG 
890 2.5 
4A Across R1 ACCGAACAACATTCGGGCAT 
3C Across F1 GACATACATCGTTGAGTTCGCA 
1250 3.5 
3C Across R1 TGCCAAGCTTATAACTACTGCT 
7E across F1 ACGAACCCTATAACTTTTTAACGCA 
910 2.5 
7E across R1 TGATACCAATCAAGTGGTCTAATGA 
7F across F1 AGTCCTTCCAAAAGTGATAGCG 
550 1.5 
7F across R1 CGCTAGAAAGGATCACTTCTTTTCA 
 
Table D1. Primer table to determine repeat length. Primer names and sequences 
used are listed. Primers were made flanking each repeats. Amplicon size deduced from 
Figure D1 is shown. Approximate repeat copy number is determined by dividing 
amplicon size by 359bp.  
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APPENDIX E INCLUSION CRITERIA FOR GENETIC SCREEN OF AGO2 
INTERACTORS  
 
Physical interactions between proteins are necessary for cellular processes. 
Numerous studies have experimentally deduced many protein-protein interactions. 
Significant efforts have been made to develop databases that curate and archive these 
experimentally discovered protein-protein interactions. Biological General Repository for 
Interaction Datasets (BioGRID) (Stark et al., 2006) is one such curated database that is 
widely used.  Different databases use different rules and systems to compile data.  In 
addition, networks that integrate major databases have been developed. This allows the 
user to retrieve interaction data using a simple user interface. One example of this, 
esyN (Bean et al., 2014), has been adopted by Flybase (http://flybase.org).  I used 
BioGRID and esyN to generate a list of Ago2 interactors (Table E1).  These sources 
provide information on interactions from researchers with different methods and 
interests, and they may or may not be relevant for our study.  A manual curation of the 
list of Ago2 interactors was required.  
Four criteria were used to rank the Ago2 interactors identified in BioGRID (Stark 
et al., 2006) and esyN (Bean et al., 2014).  The means of detecting interaction was 
scored 0 if high throughput and 1 if low throughput or validated.  Additional criteria are 
known roles in RNA interference, chromatin modification and association with 
chromatin.  Proteins received a score of 1 for each criterion satisfied and 0 if 
unsatisfied.  Values were added and presented as the Curation Score in Table E1.  
Most named proteins with a curation score of 2 or more were tested for genetic 
interaction with roX1 roX2.  Phosphatidylinositol glycan anchor biosynthesis class S 
(PIG-S, curation score 1) was also tested.  No Ago2-interactors with a score of 1 or 2 
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displayed genetic interactions with roX1 roX2 mutants, but several proteins with a score 
of 3 or 4 enhanced the lethality of roX1 roX2 males, suggesting a role in dosage 
compensation (Table E1, Figure 3.4). 
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Protein Symbol EsyN ID Database 
Curation 
score 
roX1 roX2 
interaction 
Dicer-1 Dcr-1 FBgn0039016 BioGRID 4 Yes 
Dicer-2 Dcr-2 FBgn0034246 esyN 4 Yes 
Elongator complex 
protein 1 
Elp1 FBgn0037926 esyN 4 Yes 
Fragile X mental 
retardation 
Fmr1 FBgn0028734 BioGRID 4 Yes 
r2d2 r2d2 FBgn0031951 esyN 4 No 
Rm62 Rm62 FBgn0003261 BioGRID 4 Yes 
Small ribonucleoprotein 
particle protein 1 
SmD1 FBgn0261933 esyN 4 No 
TBP-associated factor 
11 
Taf11 FBgn0011291 esyN 4 No 
vasa intronic gene vig FBgn0024183 esyN 4 Yes 
barren barr FBgn0014127 esyN 3 Yes 
belle bel FBgn0263231 esyN 3 No 
CTCF CTCF FBgn0035769 esyN 3 
No 
(previously 
tested) 
smaug smg FBgn0016070 esyN 3 Yes 
forkhead box, sub-
group O 
foxo FBgn0038197 esyN 2 No 
p53 p53 FBgn0039044 BioGRID 2 No 
I-kappaB kinase β IKKβ FBgn0024222 BioGRID 2 - 
CG9302 CG9302 FBgn0032514 BioGRID 2 - 
Phosphatidylinositol 
glycan anchor 
biosynthesis class S 
PIG-S FBgn0265190 BioGRID 1 No 
Centrosomal protein 
190kD 
Cp190 FBgn0000283 esyN 1 - 
DNA fragmentation 
factor-related protein 2 
Drep2 FBgn0028408 esyN 1 - 
gigas gig FBgn0005198 esyN 1 - 
Negative elongation 
factor E 
Nelf-E FBgn0017430 esyN 1 - 
Phosphatase and tensin 
homolog 
Pten FBgn0026379 esyN 1 - 
Phosphoinositide-
dependent kinase 1 
Pdk1 FBgn0020386 esyN 1 - 
Proteasome α7 subunit Prosα7 FBgn0023175 esyN 1 - 
pumilio pum FBgn0003165 esyN 1 - 
Purine-rich binding Pur-α FBgn0022361 esyN 1 - 
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Protein Symbol EsyN ID Database 
Curation 
score 
roX1 roX2 
interaction 
protein-α 
rapamycin-insensitive 
companion of Tor 
rictor FBgn0031006 esyN 1 - 
Ras homolog enriched 
in brain 
Rheb FBgn0041191 esyN 1 - 
Ribosomal protein S6 
kinase II 
S6kII FBgn0262866 esyN 1 - 
RNA polymerase II 
215kD subunit 
RpII215 FBgn0003277 esyN 1 - 
Tsc1 Tsc1 FBgn0026317 esyN 1 - 
Tudor staphylococcal 
nuclease 
Tudor-
SN 
FBgn0035121 esyN 1 - 
Ubiquitin-conjugating 
enzyme variant 1A 
Uev1A FBgn0035601 esyN 1 - 
 
Table E1. Ago2-interactors ranked by manual curation. Ago2 interactors were 
identified from publically available data bases, manually curated by criteria described in 
the text and ranked by curation score.  The right hand column indicates whether a 
genetic interaction with a roX1 roX2 mutant chromosome has been detected.  A (-) 
indicates that the gene has not been tested for interaction with roX1 roX2. 
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APPENDIX F DETERMINING EFFECT OF AGO2 ON H3K9ME2 ENRICHMENT AT 
1.688X REPEATS 
 
Males with the partial loss of function roX1ex40roX2Δ chromosome have normal 
survival, but synthetic lethality is observed if both copies of ago2 are mutated. This is 
accompanied by reduced X-localization of MSL complex (Menon and Meller, 2012). In 
Chapter 3 we observed Ago2 localization at many repeats. This prompted us to ask, 
what happens to H3K9me2 at the 1.688X repeats upon loss of Ago2?  To test this, I 
collected male third instar larvae from Ago2-/- and wild type flies and performed 
chromatin immunoprecipitation using anti-H3K9me2 (ab1220). The protocol used is 
described in Chapter 3. This was followed by quantitative PCR with primers listed in 
Appendix H.  
Contrary to expectation, these studies reveal that H3K9me2 enrichment 
increases over 1.688X repeats, as well as in some flanking regions (Figure F1).  
Although we do not understand why this is happening, repeat regions are typically 
silenced by H3K9me2.  I hypothesize that in the absence of Ago2, an alternative 
silencing mechanism takes over.  Future studies might be aimed at identifying the 
methyltransferase responsible for placing this mark in Ago2-/- larvae.  
  
88 
 
 
 
 
Figure F1. Loss of Ago2 increases H3K9me2 at 1.688X repeats. Chromatin from wild 
type male larvae (white), and Ago2414/414 male larvae (black) was immunoprecipitated 
with antibody to H3K9me2.  Enrichment normalized to input is shown.  Standard error is 
derived from two biological replicates.   
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APPENDIX G LOCALIZATION OF RM62 AT 1.688X REPEATS 
 
The genetic screen detailed in Chapter 3 revealed a sub-network composed of 
Ago2, Rm62, Su(var)3-9, Dcr1, and Fmr1 that interacts genetically with roX1 roX2 
mutants. Ago2 localization at the 1.688X repeats, and deposition of H3K9me2 at these 
repeats by Su(var)3-9, prompted us to ask whether Rm62 also localizes to 1.688X 
chromatin. We performed ChIP on 6-12 hr wild type embryos and embryos expressing 
1.6883F siRNA using 8 µl anti-Rm62 (Abcam, ab52809) antibody. The protocol used is 
as described in Chapter 3. This was followed by quantitative PCR using the primers in 
Appendix H.  I found that Rm62 is increased at and around 1.688X repeats by increased 
1.6883F siRNA.   
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Figure G1. Elevated 1.6883F siRNA increases Rm62 localization over and around 
1.688X repeats. Chromatin from wild type embryos (white) and embryos ectopically 
producing 1.6883F siRNA (black) was immunoprecipitated with antibody to Rm62.  
Enrichment over input was determined by quantitative PCR (qPCR).  The standard error 
of two biological replicates is shown. Primers used for analysis are presented in  
Appendix H.
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APPENDIX H PRIMER LIST 
A. Primers used for ChIP-qPCR analysis.  
ChIP for FLAG-Ago2 
Gene 
name 
Primer 
name 
Sequence 
Working 
Conc. 
(nM) 
Efficiency 
Hsp70 
hsp70 -
200F 
TGCCAG AAAGAAAACTCGAGAAA 
300 95.6 
hsp70 -
108R 
GACAGAGTGAGAGAGCAATAGTACAGAGA 
dmn 
Dmn P2 
left 
AGATTGAGCAGAAGCAGGGA 
300 99.8 
Dmn P2 
right 
CAGCAGCTCCTTGTTGTTCA 
 
ChIP at 1.688X repeats 
Amplicon 
No.  
Primer name Sequence 
Working 
Conc. (nM) 
Efficiency 
ChIP at 1.6881A1 
1 
1A F2 3' Tyn GGAATAAGCTGCGAGCCCGTAC 
150 91.3 
1A R2 3' Tyn AATGTGGTCTCGTGTGAGTACGTAA 
2 
1A1 L ND F1 AGTGCTCTGTGTGCATTGGT 
500 103.2 
1A1 L ND R1 GTGGCGAAGCCAGTTTTCAG 
3 
1A1 ND F1 TCCGATTTTTGGCAAT 
500 98.2 
1A1 ND R1 AAGCGTAAATGAAGAC 
4 
1A1 R ND F1 TGTCTTAGCCTTTAGAACTAAGTGT 
300 103 
1A1 R ND R1 CGACAAAACGCGGAATGTCTT 
5 
1A F4 G9a GACACGCCCACTTCAGTTACTGATG 
300 97.4 
1A R4 G9a CGGGTCTTATTTTCCTGGCTCG 
ChIP at 1.6883C  
1 
3CL F2 TTTTTAGCTATGCCCCGCGA 
150 93.3 
3CL R2 GGCAAGCGGAAACACTGAAG 
2 
3CL F1 CTGGCGTGAATGTAGCTCGTAA 
300 98.2 
3CL R1 GCTCCGTTTCTCTGCCGTATT 
3 
3C F1 CCAATCCAACTGTAACCCCGA 
500 94.8 
3C R1 TTTGTAAGGGGTAACATCATGAAAA 
4 
3CR F2 TCAAGGATGCTGCGGTTTTG 
300 96.8 
3CR R2 CACTCCAGCATGCAGGTTAAT 
5 
3CR F3 CCAACTTGTGTGGCTAAGCTC 
300 94.2 
3CR R3 GCCGCTTTTAGTCGGATTTCA 
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Amplicon 
No.  
Primer name Sequence 
Working 
Conc. (nM) 
Efficiency 
ChIP at 1.6883F 
1 
Ec F2 GCCAGCTAACAGGCGAATTG 
300 95.1 
Ec R2 GTCACAGCGGGAACTTCTCA 
2 
Ec F3 AGTGTTGCGACTTCAGAGCA 
300 97.9 
Ec R3 ATGTTGCTGGGCATTGGGTA 
3 
Ec F5 TGAACCAGCGCAGATGATGA 
300 99.1 
Ec R5 TCCTTGGCGGCTCCTTATTG 
4 
RNR1 F1 TATTTACAAACGGGGTTATCTCTATA
AGG 
500 
100.5 
RNR1 R3 CGTAACAAAATTTCCTATCGACCT 300 
5 
3F ChIP F3 TCGGCTCAGGCGTATAACGA 
300 102.2 
3F ChIP R3 TGAAATGAACACAGCCAAAGCA 
6 
roX1 ChIP F2 TGCCGCCAAAGACTGATGAT 
300 101 
roX1 ChIP R2 CCTTGACGAGTCCGGACAAT 
ChIP at 1.6884A 
1 
4A L ND F3        GCCATTCCCCTCCCCAGTTA 
300 92.5 
4A L ND R3        GCGATTGCTGTGCCATTTCA 
2 
4AL ND F’2       CCGCCTCTGTCGTACTTTCA 
150 90 
4AL ND R’2       TCATTTCCTTCGGCTTGGCT 
3 
4A ND F1         AAGTCTCGTAGGACGCAGGA 
150 96.9 
4A ND R1        GTACCTCGCACTTGCTGACT 
4 
4A R ND F2         CATTTGTCTGCTGCGTGAGC 
300 101.6 
4A R ND R2         TGCTGCGTCTTGACTTTCGT 
5 
4A R ND F4        CATTGAAGCGGTTGCGGATT 
150 98.7 
4A R ND R4        TGGGGTTATTTTCGGAGGGC 
ChIP at 1.6887E 
1 
7E L ND F4 AGATGTGGTCAAACACTGCG 
300 104.3 
7E L ND R4 AAACCGAAACCGAGAACCAGA 
2 
7E L ND F2 TAGCCTGACACAAGCAAGGG 
150 102.9 
7E L ND R2 GCCCGTAATGAAGTCAACCAG 
3 
7E ND F1 CTAAAAATGGCCACACAACCA 
150 99.3 
7E ND R1 GTCCTTCCAAAAGTGATAGGGATG 
4 
7E R ND F1 ACGCGGCCTTTTCATCATTT 
300 90.3 
7E R ND R1 GCCCCCTTACTCTGGCATCT 
5 
7E R ND F3 GGAAAGCCCAACCAGAATGC 
300 102.4 
7E R ND R3 GCATCGAGCGACCCAAGTTA 
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Amplicon 
No.  
Primer name Sequence 
Working 
Conc. (nM) 
Efficiency 
ChIP at 1.6887F 
1 
7F L ND F3        CCACTTGGGCTTCAATCGTA 
150 101 
7F L ND R3         GCTTGGGGAATACGAGGCA 
2 
7F L ND F2         TCTGGTCCTTCGCTGCATTT 
150 102.5 
7F L ND R2         GCGACGATATTTGCCTTGGG 
3 
7F ND F2         ATCGCCCACCAAGAATCACC 
150 101.8 
7F ND R2         TCTTCTTCTCGTGCCTTTGCT 
4 
7F R ND F2         ATGCAGGTCGCATTGAGGAA 
150 107 
7F R ND R2        CAATGGTCACCCACCCAAGT 
5 
7F R ND F4        CGACGTTGGCAGAATAGCAA 
300 94.7 
7F R ND R4        CCAAAGGAAAAGCGCACACA 
 
ChIP at a distance from repeats 
Gene 
name 
Primer name  Sequence 
Working 
Conc. 
(nM) 
Efficien
cy 
cin 
Cin F2 CTGGTAGCGAAAAGGCCGTA 
150 101.8 
Cin R2 CCTCAGCATGTGTTTTCCGC 
opt1 (yin) 
Yin F GGTGATTGCCGAATTCAAGT 
300 110.1 
Yin R ACTAGCATAAGGCTGGCGAA 
CG43689 
CG43689 F1 CCCCACAGGTGAGTCATTCC 
300 102.1 
CG43689 R1 TGCGGGCTCGTAATAATGCT 
CG1387 
CG1387 F1 ACGCTCCATGTCCTTTACGG  
300 95.7 
CG1387 R1 CGTTTCGCTTTGCTTTTGCG  
IntS4 
IntS4 F1 CACACAGCGGCGTATTTTGT 
300 94.9 
IntS4 R1 TGCCCATGAAAGAGTCGGTC 
 
ChIP at 2L integration site  
Amplicon 
No. 
Primer name Sequence 
Working 
Conc. 
(nM) 
Efficien
cy 
1 
SJTG-5kbL flanking 
F1 
AGTTCATCGCCGGATCACTG 
150 97.7 
SJTG-5kbL flanking 
R1 
AAAGCGGAGCAGATGGACTT 
2 
SJTG-L flanking F1 TCGACTTTGCTCAACACACAA 
500 97.3 
SJTG-L flanking R1 ACCCGCATTTCCATTTTGCG 
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3 
1.6883F 
insertion 
roX1 
HincIIR 
CTCAATAGCATAAAAAATAGTT
GACC 
300 91.3 
Sat_LoxP
_R 
CGACCGTTGCGGCCTTCGTAT
AGCAT 
3 
roX1 
insertion 
roX1R_7
06 
TCATATCCACTAGCATAAGGCT
GGCG 
300 103.4 
roX1_Lox
P_F 
ATCGGTCGGCGGCTTCGTATA
ATGTA 
4 
SJTG-R flanking F1 TACAGTAAGCCACCACCGAT 300 
97.6 
SJTG-Rflanking R1 GCGGCAGTCTGTTATCTCTGT 500 
5 
SJTG-5kbR flanking 
F2 
GTCTGTAGCAGCAAGCGGTA 
150 94.2 
SJTG-5kbR flanking 
R2 
ATCCTGTTGACTGACTGCCG 
        
B. Primers used for Quantitative RT-PCR primers 
 
Genes on 2L and normalizer 
Gene 
name 
Primer name Sequence 
Working 
Conc. 
(nM) 
Efficien
cy 
CG33128 
J1_F2 AACCGACCAGAACCTCATCG 
150 98.4 
J1_R2 TCACGGTTCCATTCCAGGTG 
haf 
Hap F2 AGCTGAACCTGCTGGATTT 
300 95.6 
Hap R2 AGGGTGGACAGCTTTGTTAG 
RFeSP 
J2_F3 AAATGATGAACGCCGTGTCG 
300 89.2 
J2_R3 GCAGAGCCTTACCCATCGAG 
Eno 
J3_F1 ATGTCTTGGACCGCTTCAGT 
150 102.1 
J3_R1 GCCCTTTCGATTGGGGTGA 
CG31778 
J10_F2 AACCATTCACTGCAGAGGCG 
150 95.7 
J10_R2 CCGAAGTCATTGCCCTCAGAA 
Rpl37A 
J8_F1 GAGCGCCAAATGGTGACAAA 
500 108.6 
J8_R1 CAGGACCAGATGCCCACAAC 
dmn 
Dmn_F GACAAGTTGAGCCGCCTTAC 
300 98.5 
Dmn_R CTTGGTGCTTAGATGACGCA 
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ABSTRACT 
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DROSOPHILA MELANOGASTER X CHROMOSOME 
 
by 
 
NIKITA DESHPANDE 
August 2018 
Advisor: Dr. Victoria H. Meller 
Major: Biological Sciences 
Degree: Doctor of Philosophy 
 
Eukaryotic genomes are organized into large domains of coordinated 
regulation. The role of small RNAs in formation of these domains is largely 
unexplored. An extraordinary example of domain-wide regulation is X 
chromosome compensation in Drosophila melanogaster males. This process 
occurs by hypertranscription of genes on the single male X chromosome. 
Extensive research in this field has shown that the Male Specific Lethal (MSL) 
complex binds X-linked genes and modifies chromatin to increase expression. 
The components of this complex, and their actions on chromatin, are well 
studied. In contrast, the mechanism that results in exclusive recruitment to the X 
chromosome is not understood. Our research focuses on the process by which 
male flies selectively modulate expression from their single X chromosome. Prior 
studies in the laboratory have found that the siRNAs produced from repetitive 
sequences on the X chromosome and the repeat DNA itself, participates in 
dosage compensation in flies. Interestingly, the siRNA pathway contributes to X-
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localization of the MSL complex. The basis of enhanced localization is unknown, 
and no RNAi components have been found to interact directly with the MSL 
complex. This suggests that siRNA influences X-recognition by an indirect and 
novel mechanism. I found evidence that chromatin around these repeats is 
modulated by the siRNA pathway. I demonstrated that FLAG-tagged Argonaute2 
protein localizes at these repeats. We show that numerous Agonaute2-
interacting proteins show evidence of participation in compensation. One of 
these, Su(var)3-9, deposits H3K9me2 in and near the repeats. When a repeat-
containing transgene is inserted on an autosome, H3K9me2 is enriched in 
surrounding chromatin, an effect that is enhanced by ectopic production of 
cognate siRNA. In accord with the idea that these repeats contribute to 
recruitment of dosage compensation, genes as much as 100 kb from the 
autosomal insertion increase in expression upon expression of ectopic siRNA. 
My studies demonstrate that chromatin around a group of X-enriched sequences 
is modulated by siRNA, and supports the idea that siRNA contributes to the 
elevated expression that characterizes the compensated male X chromosome. 
This study advances our understanding of the mechanism of X recognition by 
showing a direct relationship between siRNA-directed chromatin modification and 
a class of repetitive elements that helps mark the X chromosome. 
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